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ABSTRACT 
 
Dickkopf-1 (Dkk1) is a potent inhibitor of the Wnt/β-catenin signaling pathway 
in both tooth and bone development. Deletion of the Dkk1 gene in mice leads to 
embryonic lethality, whereas transgenic mice over-expressing Dkk1 in mature 
osteoblasts result in osteopenia. Targeted expression of Dkk1 in dental epithelial cells 
leads to the formation of dysfunctional enamel knots and subsequent tooth defects 
during embryonic development. However, the direct role of Dkk1 in post-natal 
dentinogenesis and calvarial osteogenesis is largely unknown. To address this issue, we 
analyzed 2.3-kb Col1a1 Dkk1-transgenic (Tg) mice, which over-express Dkk1 in 
immature and mature odontoblasts and osteoblasts.  
The Dkk1 transgene was highly expressed in pulp and odontoblast cells during 
post-natal developmental stages. A disruption in tooth development was obvious with 
the 1st mandibular molar displaying short roots, an enlarged pulp/root canal region, and a 
decreased dentin formation rate. Also within the mandible, the 2nd molar is small and 
malformed and the 3rd molar is absent. The molars possess an increased number of 
immature odontoblasts, very few mature odontoblasts, and a sharp reduction in dentinal 
tubule number accompanying a dramatic change in expression of certain odontoblast 
markers, such as Osterix and Nestin. 
 The calvarial bone presents with a significantly pronounced bone defect within 
Dkk1-Tg mice. The defect exhibits a markedly reduced calvarial bone density and 
multiple regions lacking any bone mineralization, which is indicative of an osteogenic 
deficiency. A greater than 60% reduction of parietal bone volume as well as an 
incomplete articulation of the parietal bones abutting the sagittal suture is evident. 
Irregularly shaped and abnormally small osteocytes are housed within the 
underdeveloped bone presenting more as osteoblastic-like cells in structure/function. 
Most obviously, the calvaria rather unusually presents with a considerable increase in 
osteoclast cell number, maturation, and activity present on the endo-cranial surface. An 
increase in immature osteoblast markers, as well as a decrease in mature osteoblast 
  iii 
markers combined with an increase in active osteoclast markers was evidence of a 
disrupted bone homeostasis. 
From our studies we propose that within molar development and calvarial bone 
development, Dkk1 over-expression disrupts post-natal dentin formation and instigates 
an uncoupling of the osteoblastic/osteoclastic bone remodeling activities in favor of bone 
resorption with an increase in osteoclast-mediated destruction. Dkk1 is able to exert its 
effects directly via the inhibition of Wnt signaling or indirectly via its regulation of 
Osterix expression. 
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NOMENCLATURE 
 
 
µCT Microcomputer Tomography 
β-Cat Beta-Catenin 
ALP Alkaline Phosphatase 
APC Adenomatous polyposis coli 
AXIN Axis inhibition protein 
BAC Bacterial Artificial Chromosome 
BSP Bone Sialoprotein 
CatK Cathepsin K 
cKO Conditional Knockout 
Cre Cre “causes recombination” recombinase 
DKK1 Dickkopf-1 
DMP1 Dentin Matrix Protein 1 
ECM Extracellular Matrix 
ER Estrogen Receptor 
FRZD Frizzled 
GOF Gain of Function 
KI Knock-in 
KO Conventional Knockout 
LacZ β-Galactosidase 
LOF Loss of Function 
LoxP Lox sequence 
LRP Low-density lipoprotein receptor-related protein 
MM Multiple Myeloma 
MMP Matrix metalloproteinase 
OB Osteoblast 
OC Osteoclast 
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OCN Osteocalcin 
OPG Osteoprotegerin 
OSX Osterix 
PDL Periodontal Ligament 
RANK Receptor activator of nuclear factor kappa 
RANKL Receptor activator of nuclear factor kappa ligand 
SEM Scanning Electron Microscopy 
SOST Sclerostin 
TCF T cell factor 
TG Transgene/Transgenic 
TK Thymidine Kinase 
TRAP Tartrate-resistant acid phosphatase 
Wnt Wingless  
WT Wild type 
 
 
 
 
 
  viii 
TABLE OF CONTENTS 
 
 Page 
ABSTRACT ....................................................................................................................... ii 
DEDICATION .................................................................................................................. iv 
ACKNOWLEDGEMENTS ............................................................................................... v 
NOMENCLATURE .......................................................................................................... vi 
TABLE OF CONTENTS ................................................................................................ viii 
LIST OF FIGURES ............................................................................................................ x 
CHAPTER I INTRODUCTION AND LITERATURE REVIEW .................................... 1 
Introduction ............................................................................................................ 1 
Literature Review ................................................................................................... 2 
CHAPTER II APPLICATION OF GENETICALLY ENGINEERED MOUSE  
MODELS IN CRANIOFACIAL BIOLOGY RESEARCH ............................................. 12 
 
Overview .............................................................................................................. 12 
Introduction .......................................................................................................... 12 
Terminology ......................................................................................................... 14 
Practice and Application ...................................................................................... 16 
Discussion ............................................................................................................ 27 
CHAPTER III POSTNATAL EFFECT OF OVEREXPRESSED DKK1 ON 
MANDIBULAR MOLAR FORMATION ....................................................................... 29 
 
Overview .............................................................................................................. 29 
Introduction .......................................................................................................... 30 
Experimental Procedures ...................................................................................... 31 
Results .................................................................................................................. 33 
Discussion ............................................................................................................ 36 
CHAPTER IV EFFECTS OF OVER-EXPRESSING DKK1 ON OSTEOBLAST  
AND OSTEOCLAST HOMEOSTASIS .......................................................................... 39 
 
Overview .............................................................................................................. 39 
Introduction .......................................................................................................... 40 
Experimental Procedures ...................................................................................... 43 
  ix 
Results .................................................................................................................. 46 
Discussion ............................................................................................................ 50 
CHAPTER V CONCLUSION ......................................................................................... 54 
 
Role of Dkk1 in Odontogenesis ........................................................................... 54 
Role of Dkk1 in Cranial Vault Osteogenesis ....................................................... 56 
 
REFERENCES ................................................................................................................. 60 
APPENDIX A FIGURES ................................................................................................. 71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  x 
LIST OF FIGURES 
 Page 
Figure 1-1 Generation of a transgenic mouse .................................................................. 71 
Figure 1-2 Generation of gene targeted mice using embryonic stem (ES) cells .............. 73 
Figure 1-3 Dmp1-lacZ knock-in mouse line: A useful model for studying gene 
expression and function in craniofacial development .................................... 74 
 
Figure 1-4 Creation of Cre-loxP bone/tooth-specific conditional knockout model ......... 76 
 
Figure 1-5 Cre-loxP model utilizing lacZ staining in craniofacial development ............. 77 
Figure 1-6 Tamoxifen (Tm), an antagonist of estrogen, induced tissue specific 
conditional knockout (cKO) of Osx (Osterix) in cementum .......................... 79 
 
Figure 2-1 Expression patterns of the 2.3-kb Col1a1 Dkk1-Transgene (Tg) during  
 tooth development .......................................................................................... 80 
 
Figure 2-2 Dkk1-Tg mice display a severe mandibular molar defect .............................. 82 
Figure 2-3 Dentin erosion in the Dkk1-Tg lower first molar ........................................... 84 
Figure 2-4 Dkk1-Tg mice have an increased expression of OSX in immature molar 
odontoblasts .................................................................................................... 86 
 
Figure 2-5 Dkk1 expression pattern during post-natal tooth development ...................... 88 
Figure 2-6 Radiograph image displays absence of 3rd mandibular molars in Dkk1-Tg 
mice ................................................................................................................ 89 
 
Figure 2-7 Relatively mild maxillary molar phenotype present in Dkk1-Tg mice .......... 90 
Figure 2-8 Unpolarized odontoblasts (Od) in the Dkk1-Tg mandibular molar ................ 91 
Figure 2-9 2.3-kb Col1a1 promoter activity in both pulp and odontoblast cells ............. 92 
Figure 3-1 Schematic of Dkk1-Tg mice promoter construct and relative expression  
 levels of the Dkk1-transgene .......................................................................... 93 
 
Figure 3-2 Calvarial osteolytic lesions develop in 2.3-kb Col1a1 Dkk1-Tg mice ........... 94 
  xi 
Figure 3-3 Microcomputed tomography (µ-CT) displays mineralization deficiency in 
calvarial bones ................................................................................................ 95 
 
Figure 3-4 Decreased dendritic processes, misshapen osteocytes, and decreased 
mineralization in Dkk1-Tg parietal bone ........................................................ 97 
 
Figure 3-5 Normal suture fusion of Dkk1-Tg posterior frontal bones ............................. 99 
Figure 3-6 Increase in ecto-cranial bone formation and a decrease in endo-cranial  
 bone formation in Dkk1-Tg parietal bone .................................................... 100 
 
Figure 3-7 Increase in Dkk1-Tg osteoclast maturation and activity ............................... 101 
Figure 3-8 Wnt/β-catenin signaling in Dkk1-Tg mice: Increased in osteoclasts and 
decreased in osteoblasts and osteocytes ....................................................... 103 
 
Figure 3-9 Increase in trabeculation in the under-mineralized bone as well as an  
 increase in Osx: an osteoblast marker .......................................................... 104 
 
Figure 3-10 Increase in Osx gene expression independent of Runx2 ............................. 105 
Figure 3-11 An increase in immature osteoblast markers Bsp and Opn in Dkk1-Tg 
parietal bone ................................................................................................ 106 
 
Figure 3-12 An increase in expression of immature osteoblast markers: Bsp, Opn  
 and Alp, along with a decrease in expression of Ocn, a mature  
 osteoblast marker within the Dkk1-Tg parietal bone .................................. 107 
 
Figure 3-13 Increase in parietal bone Sost and Dmp1 in Dkk1-Tg calvaria .................. 108 
Figure 3-14 Increase in Sost and Dmp1 gene expressions in Dkk1-Tg primary  
 parietal bone assay ...................................................................................... 109 
 
Figure 3-15 Working hypothesis: Dkk1 indirectly induces Osterix expression ............ 110 
 
 
  1 
CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
 
Introduction 
Bone and tooth development have been meticulously investigated in the field of 
craniofacial research as their formation are instrumental to life. Genes and proteins 
involved in their formation have been sought after for decades and many have been since 
discovered and intensely researched to allow for the piecing together of key signaling 
pathways. It is imperative to continue these studies as therapeutics depends on our 
discoveries and disclosure of the mechanics of intricate signaling pathways. The Wnt 
signaling pathway is one signaling pathway that is crucial in all areas of development 
from early embryogenesis, through organogenesis and beyond. The role of Wnt 
signaling in bone and tooth formation has been explored but through the generation and 
utilization of mouse models its role in these developmental processes became less 
concrete and warranted further analyses for a more thorough understanding. 
Craniofacial research has been made possible and has progressed over the years 
through the creation and implementation of mouse models. Genetically engineered mice 
are powerful animal models used for studying cutting-edge craniofacial research 
analyzing developmental and disease states affecting tooth, bone and cartilage. These 
techniques have been well established over the past few decades and allow for any gene 
of interest to be genetically modified in a predetermined way based upon basic and 
clinical research needs. These mouse models are created and analyzed in hope that their 
use in research will initiate translational approaches for enhanced understanding of 
human diseases and enhance subsequent patient treatment.  
Chapter I provides the basic foundation of knowledge for medical/dental 
researchers to further understand how genetically engineered mice are generated. It also 
details on how to select for utilization specific mouse models directed towards specific 
  2 
research areas, and will elaborate on the advantages and disadvantages of using different 
mouse models. 
Chapters II and III delve in-depth into the specifics of the 2.3-kb Col1a1 Dkk1-
Tg mouse model. This mouse model over-expresses the Dickkopf-1 (Dkk1) gene under a 
specific collagen type 1 alpha1 promoter. This promoter is a 2.3-kb fragment of the rat 
collagen 1 promoter, which is active in immature and mature odontoblasts and 
osteoblasts. Chapter II focuses on the use of the mouse model to study the role of Dkk1 
in tooth morphogenesis, more specifically within dentinogenesis. Chapter III explores 
the role of Dkk1 in calvarial osteogenesis and how the time and location specific over-
expression of the Dkk1 gene causes major disruptions in bone homeostasis, and hence an 
altered regulation of bone formation and resorption.  
 
 
Literature Review 
Wnt/β-catenin signaling pathway 
The Wnt/β-catenin signaling pathway is inherently a very complex pathway with 
an indispensible role in many developmental processes including, but not limited to, 
bone and tooth development (1-5). The Wnt proteins form a family of highly conserved 
secreted glycoprotein signaling molecules that regulate cell-to-cell interactions during 
embryogenesis. Mutations in the Wnt signaling pathway have known to cause many 
developmental defects and diseases (1). Wnt signaling is greatly involved in controlling 
cell proliferation, stem cell maintenance and cell fate decisions, as well as organized cell 
movements and the establishment of tissue polarity (6). Key players in the pathway 
include the classical Wnt receptor and the Frizzled (Frzd) receptor, a seven-pass 
transmembrane receptor possessing a cysteine-rich domain for the Wnt protein to bind 
to. Another known family of proteins in the signaling pathway is the low-density 
Lipoprotein Receptor-related Protein (LRP) family, two of the members, Lrp-5 and Lrp-
6, being single-pass transmembrane co-receptors for Frzd. Wnts bind to Fzld family 
receptors and Lrp-5/6 co-receptors. These co-receptors have a relatively small 
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intracellular domains and a large extracellular domain containing several potential 
protein interaction domains.  
In the absence of Wnt, β-catenin forms a complex with the APC, Axin and 
glycogen synthase kinase 3, which facilitates phosphorylation and proteosomal 
degradation of β-catenin. Stimulation of these receptors by Wnts leads to the 
intracellular molecule β-catenin to accumulate and translocate into the nucleus, where it 
interacts with the TCF/Lef1 transcription factor to activate transcription of target genes 
(7). Conditional inactivation of β-catenin in either skeletal progenitor cells or at a later 
stage of osteoblast development in mouse embryos blocks osteoblast differentiation (7). 
Dkk1 and Sost are antagonists that prevent the Wnt protein from activating the Frzd/ 
Lrp5/Lrp-6 receptor-signaling pathway leading to a decrease in signaling (7). The Wnt 
pathway in tooth and bone development is very complex as there are many different 
genes involved that either are Wnt affecters or are Wnt effectors. Studies have been 
performed in vivo and in vitro to further understand how Wnt interacts with other key 
factors and proteins. 
 
Dickkopf-1 
Although significant progress has been made studying gene mechanisms in bone 
and tooth development within the last decade, the role of Dkk1 in their formation during 
postnatal development is largely unknown. Dkk1, a major inhibitor of the Lrp-5/Lrp-6 
co-receptors, is characterized as a soluble, secreted protein that, when bound to the co-
receptors blocks their interaction with Wnt proteins resulting in β-catenin degradation 
and subsequent effects on cell proliferation (3, 8-10). Dkk proteins have also been linked 
to canonical and non-canonical signaling events. Conventional deletion of the Dkk1 gene 
in mice led to embryonic lethality with the embryos lacking anterior head structures (11) 
and an elimination of Dkk1 expression in osteoblasts resulted in an increase in bone 
formation and mass (12). On the contrary, over-expression of Dkk1 under the 2.3-kb 
Col1a1 promoter resulted in severe defects in bone formation as well as molar tooth 
development (13). 
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Dickkopf-1 and tooth development  
 The mouse has a very reduced dentition compared to humans, but it still 
possesses molars and incisors and a dental developmental process that is very similar to 
humans. A major difference is that the mouse has only one dentition instead of a primary 
and a permanent dentition as seen in humans. Various stages of tooth development occur 
during embryogenesis and beyond. At E11.5 (embryonic day 11.5) the oral epithelium 
thickens and cell proliferation increases at the sites of future tooth formation (14). The 
ectoderm-derived epithelium then undergoes an invagination into underlying neural 
crest-derived mesenchyme, and these processes lead to the formation of a tooth bud. 
Within the developing tooth, Dkk1 is expressed in the dental mesenchyme. At E12 the 
underlying mesenchyme condenses around the tooth bud and takes over the instructive 
role from the epithelium for future tooth formation. Overexpression of Dkk1 in the early 
oral epithelium lead to a cessation of tooth formation at the bud stage (15).   
Dkk1 has already been established as a major inhibitor of the Wnt signaling 
pathway and Wnt proteins are thought to play a significant role during the bud stage of 
tooth development. Within the developing tooth, Dkk1 shows a distinct spatiotemporal 
pattern of expression. It is not until E13.5, during bud stage, when Dkk1 presents itself 
for the first time expressed within the molar tooth germ within the epithelial bud. 
A specific structure, known as the enamel knot, then forms at the tip of the bud 
driven by mesenchymal signaling to the overlying epithelium. The enamel knot has been 
heavily studied and expresses a plethora of tooth signaling molecules, therefore this 
structure became known as a very important signaling center for tooth morphogenesis. 
Although the cells of the enamel knot do not proliferate, the structure itself has been 
associated with cusp formation. Disruption in knot formation leads to cuspal defects. 
Secondary enamel knots then form and the inner enamel epithelium then folds. This 
initiates the bell stage, which occurs around E16.5. Secondary knots dictate the 
formation of multiple cusps on a mouse molar tooth. At E14 during early cap stage 
through E14.5 late cap stage and through to E16 early bell stage, Dkk1 expression is 
seen at the cervical region of the mesenchymal dental papilla (16). After the loss of the 
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secondary enamel knots, cells within the tooth organ start their differentiation into their 
final forms: inner enamel epithelial cells differentiate into ameloblasts and dental pulp 
mesenchymal cells differentiate into odontoblasts. At around E18 (right before birth) 
Dkk1 expression shifts to the cuspal region within the dental papilla, more specifically to 
the pre-odontoblasts, which are located under the inner dental epithelium at the tips of 
the future cusps. 
Differentiated ameloblasts form a mineralized enamel matrix and differentiated 
odontoblasts form dentin. Pre-odontoblasts form first and then differentiate into 
polarizing odontoblasts, then into secretory/functioning odontoblasts and lastly into 
mature terminally differentiated odontoblasts (17). At PN2 (post-natal day 2), Dkk1 
expression is still very intense in the pre-odontoblasts. The odontoblasts and dental 
lamina expresses much weaker Dkk1 signal at this time period but the signal is sustained 
into the secretory odontoblast stage (16). The overall signaling pattern of Dkk1 
throughout tooth development shows a shift from epithelium to mesenchyme but is 
primarily expressed in postnatal mesenchymal-derived cells.  
Wnt/β-catenin signaling in the dental epithelium is critical for dental patterning 
during multiple stages of early tooth development. Supportive evidence includes 
constitutive activation of β-catenin in the epithelium, which causes the formation of 
large malformed tooth buds and ectopic teeth (18). Alternatively, blocking Wnt/β-
catenin signaling through the targeted expression of Dkk1 in epithelial and underlying 
mesenchymal cells led to the formation of blunted molar cusps (i.e., blocking the 
secondary enamel knots) (18). The role of Wnt signaling in the dental mesenchyme 
during tooth patterning is controversial. Chen et al. showed that the inactivation of β-
catenin resulted in tooth arrest at the bud stage in both molars and incisors (19). 
Recently, Lohi et al. showed that Axin2 lacZ signal, which reflects the canonical Wnt 
signaling pathway, is expressed in dental pulp and developing odontoblast cells, but not 
in ameloblast cells postnatally (20), suggesting a potential role for canonical Wnt 
signaling in post-natal tooth formation. Although Dkk1 mRNA is expressed in the dental 
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papilla, pre-odontoblasts, and odontoblasts (16), its function in post-natal dentin 
formation is largely unknown.   
 
Cranial vault development 
The entire process of cranial vault development occurs first by the formation, 
migration and commitment of skeletogenic mesenchymal precursor cells followed by 
subsequent differentiation and proliferation of osteogenic bone cells. In contrast to long 
bones, cranial vault bones are derived from two tissues with separate origins: paraxial 
mesoderm and neural crest. The vault bones are formed through intramembranous bone 
formation during which mesenchymal cells condense and differentiate into 
osteoprogenitor cells then to osteoblast cells, a process which is different endochondral 
bone formation (21, 22). The cranial vault is composed of the paired frontal and parietal 
bones with a lesser contribution from the post-parietal (inter-parietal) bone. Growth of 
the mammalian cranial vault takes place mainly in the fibrous joints (sutures) between 
these bones, all of which differentiate directly within the mesenchyme that lies between 
the brain and the surface ectoderm. The overall growth of the cranial vault, made up of 
multiple different bones, including the paired frontal and paired parietal bones, allows 
for brain growth and suture formation within the boundaries of the vault bones (23). The 
osteogenic fronts, or leading edges of the bones, grow towards each other and when they 
come together there is either fusion between the two to create a single bone (only the 
posterior aspect of the frontal bones in mice fuses) or the bones abut one another and 
sutural tissue remains. A suture is composed of the two osteogenic fronts and the 
interposing mesenchymal tissue (9). After migration and commitment of mesenchymal 
cells, osteogenic precursors differentiate into osteoblasts and secrete a mineralized 
matrix to form the cranial vault bones. The specific process of cranial vault bone 
formation occurs by intramembranous ossification involving a direct differentiation of 
condensed mesenchymal cells rather than the process of endochondral ossification 
involving mesenchymal condensation to form a cartilaginous intermediate (24). Bone 
formation occurs in stages during mouse development and a complex variety of genes 
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are involved. By E12.5 (embryonic day 12.5) during mouse development mesenchymal 
condensations on the lateral sides of the head start to form the frontal and parietal bone 
rudiments. These condensations, bearing osteogenic activity, spread dorsally. These 
bones are intramembranous and thus develop without a preceding cartilaginous 
primordium (25) with apposition of these bones occurring mostly on the outer bone 
surfaces (25). At E14.5, the immature osteoblasts residing at the osteogenic fronts of the 
developing bones differentiate to produce a bone matrix. Ossification of the calvarial 
bones starts within centers of condensing mesenchymal cells, in which the osteoblasts 
subsequently differentiate. The sutures that form between the two bone fronts are the 
primary sites of osteoblasts differentiation and bone formation (26).  By E15, the 
osteogenic fronts of the parietal bone are approximating each other, but are still widely 
separated by a region of mesenchymal tissue within the sagittal sutural region (10). By 
E15.5, a primary sagittal suture is formed in the midline where the ends of the cellular 
masses meet. From this point until birth (around E16.5), a relative amount of 
mesenchyme is reduced as the osteogenic fronts move together in an end-to-end fashion. 
It is important to note that mid-sutural mesenchymal cell populations are not 
likely to contribute to calvarial bone formation but rather remain undifferentiated. 
Conversely, the small population of mesenchymal cells lining the parietal bone 
osteogenic fronts are able to differentiate into the osteoblastic lineage, displaying a 
relationship between mesenchymal cell position and its contribution to osteogenic 
activity within the suture. Intramembranous bone growth is therefore shown to occur 
through proliferating osteoprogenitor cells at the osteogenic bone fronts as well as a 
contribution from the sutural mesenchyme (9). 
 
Genetic regulation of bone 
Bone extracellular matrix (ECM) contains two types of proteins: the collagens, 
mostly type I collagen, which accounts for 90% of the bone matrix proteins, and the non-
collagenous proteins, including Osteocalcin, Osteopontin, and Bone sialo-protein (27). 
In 1999, Runx2 was the only osteoblast-specific transcription factor that had been 
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identified, and it was seen to act as an activator of osteoblast differentiation during 
embryonic development (27). Runx2 has an indispensable role in ECM deposition, and 
inhibition of this auto-regulatory cascade results in an osteopenic phenotype caused by 
the near abolition of expression of ECM-related genes, including type I collagen-
encoding genes, without any overt effect on osteoblast differentiation (27). No 
membranous or endochondral bones are formed in Runx2-null mice (7) and therefore it 
is certain that Runx2 is needed for mesenchymal cell differentiation into pre-osteoblastic 
cells (7). Runx2 regulates osteoblast-specific expression of Osteocalcin (Ocn) and 
Osteopontin (Opn) (27). Runx2 has also been documented to regulate the expression of 
Osterix (Osx), a zinc finger transcription factor involved in osteoblast differentiation. 
Inactivation of Runx2 in mice has shown that this gene is an indispensable regulator of 
osteoblast differentiation as the mice have a total lack of osteoblasts in homozygous 
mutant animals and die prenatally (27). Osteocalcin (Ocn) is a gene that is not expressed 
prenatally and has been dubbed as a hallmark gene for a differentiated osteoblast (27). 
The expression of this gene is virtually absent before birth and its restricted to 
differentiated osteoblasts able to produce a bone ECM, and is absent in osteoblast 
progenitors (27).  
In the presence of a normal number of osteoblasts in the bone matrix, an 
osteopenic phenotype could develop only if each osteoblast produces less of the various 
proteins required to form the bone ECM (27). The differentiation of the osteoblasts 
forming the bone matrix in the process of intramembranous ossification is regulated by a 
number of transcription factors and signaling factors including Osx, Runx2 and the Wnt 
signaling pathway (28).  
Bone formation is regulated by many different bone markers expressed through a 
few different pathways. Osx is a key player in bone formation whose expression has 
been previously documented to be under the control of Runx2. Runx2 knock-out (KO) 
mice lack bone formation completely and Osx KO mice are unable to form bone due to 
an arrest of osteoblast differentiation. Interestingly, an overexpression of both Runx2 and 
Osx under the expression of the 2.3-kb Col1a1 promoter leads to an osteopenic 
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phenotype in the long bones similar to that which is seen in 2.3-kb Col1a1 Dkk1-Tg 
mice. Osx is known to be pivotal in osteoblastic differentiation during the early stage of 
osteoblast differentiation, but during the later stages it has become evident that Osx has 
an inhibitory function leading to an accumulation of immature osteoblasts. Runx2 
regulation of Osx expression has been previously documented as well as Osx expression 
being regulated by the Bone morphogenetic protein (Bmp) pathway. A potential 
interaction between the Wnt signaling pathway and the Bmp pathway has been identified 
that could lead to the regulation of Osx expression independent of Runx2. 
 
Bone homeostasis: osteoblasts and osteoclasts 
Pivotal cells in bone formation, regulation and turnover include the osteoblasts 
and the osteoclasts. The osteoblasts are the cells responsible for bone formation whereas 
the osteoclasts are terminally differentiated, multinucleated cells responsible for bone 
resorption. These two cell types work in collaboration with one another to maintain bone 
homeostasis (29). To promote osteoclast differentiation osteoblasts secrete Receptor 
activator of nuclear factor kappa-B ligand (Rankl), which is then free to bind to Rank, a 
protein expressed by osteoclasts (30). Osteoblasts also secrete macrophage-colony 
stimulating factor (M-csf), which has shown an effect in osteoclast differentiation, but is 
not needed for the resorbing activity of osteoclasts (31). The counter-response to Rankl-
Rank binding and osteoclast differentiation into a multinucleated osteoclast is modulated 
by the osteoblasts' expression of Osteoprotegerin (Opg), a decoy receptor. Opg binds to 
Rankl, preventing Rankl from binding Rank, thereby preventing osteoclastogenesis (32). 
Determination of the extent of normal bone resorption depends heavily on the ratio of 
Rankl:Opg. Once activated, osteoclasts stimulate resorption and degradation of the 
boney matrix, by expressing enzymes, such as tartrate-resistant acid phosphatase (Trap), 
a glycosylated monomeric metalloenzyme, Cathepsin K, a lysosomal cysteine protease, 
and matrix metalloproteinase-9 (Mmp-9), an extracellular matrix proteinase. These 
proteins are secreted into the osteoclasts’ lacunae, the space between the cell and their 
attachment site to the extracellular mineralized matrix, and degrade the matrix (33). 
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Dickkopf-1 and multiple myeloma disease 
Osteoclastic bone resorption has been indicated in patients with osteolytic bone 
diseases such as multiple myeloma (34). Speculation as to the driving force behind 
multiple myeloma lytic bone disease include both osteoblastic inhibition (such as with 
an over-expression of Dkk1) (35), and osteoclastic stimulation leading to an uncoupling 
of bone homeostasis. Dkk1 negatively regulates Wnt/β-catenin signaling and in turn 
functions as a critical regulator of bone physiology. Specific aspects of the Wnt/β-
catenin signaling pathway have been studied within osteoblasts but a relatively scant 
amount of research has focused on the crosstalk of Wnt/β-catenin signaling and Bmp 
signaling in osteoblasts. Studying the effects of Dkk1 on bone in the very serious and 
devastating lytic bone disease in humans (36, 37). Research has shown that there is a 
definitive link between patients with multiple myeloma and an over-secretion of Dkk1 
from the patients’ plasma cells (35, 38, 39). Elevated levels of Dkk1, present in the 
plasma and peripheral blood, were then subsequently correlated with the formation of 
lytic bone lesions and the “punched out” bone lesions in the calvarium. Bone marrow 
biopsy specimens stained for Dkk1 exhibited very elevated levels, and also presented 
with an increased Dkk1 antibody staining within plasma cells adjacent to the bone (36, 
40). Furthermore, Dkk1’s involvement in multiple myeloma links the over-expression of 
the Dkk1 protein to a disruption in the balance between osteoblastic and osteoclastic 
activity. Patients with multiple myeloma have presented with markedly increased 
osteoclastic activity in contrast to a significantly diminished osteoblastic activity. The 
osteolytic lesions formed in a significant amount of patients with multiple myeloma 
seem to occur due to osteoclastic hyper-activation combined with osteoblastic inhibition.  
Increased Dkk1 expression has been found to be associated with lytic bone 
lesions, which form in patients with multiple myeloma, a devastating disease. This 
suggests that Dkk1 might therefore inhibit osteoblast differentiation and/or function (36, 
41). This finding has been reinforced by data disclosing Dkk1 as a powerful negative 
regulator of osteoblast function in vitro and in vivo. It has also been shown that a 
decrease in Dkk1 expression is sufficient to induce a potent anabolic response in bone 
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(12, 13, 42). Studies have also shown that there is an association between serum Dkk1 
levels and BMD (bone mineral density) (41). 
 
Dickkopf-1: further evidence unveiling crosslinking of Wnt and BMP pathways 
In this study we aimed to determine the effects of over-expressing Dkk1 in 
mature osteoblasts to further study the effect on osteoclastic activity and bone 
homeostasis. The Dkk1-Tg mouse model allows for concentration on determining the 
relationship between Dkk1 expression and osteoblastic/osteoclastic activity as it is still 
unclear how the over-expression of Dkk1 in osteoblasts affects osteoclastic activity. Here 
we present a hypothesis by which Dkk1 negatively regulates the Wnt signaling pathway, 
which then has the potential to release the Wnt inhibitory effect on the BMP pathway 
which allows for the stimulation of Osterix expression. Osterix expression at this later 
time point in osteoblast differentiation acts as a blocker of osteoblast differentiation from 
immature osteoblasts into mature osteoblasts. Osterix expression also regulates RANKL 
and M-CSF expression increasing osteoclastogenesis (43, 44). 
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CHAPTER II 
 
APPLICATION OF GENETICALLY ENGINEERED MOUSE MODELS 
IN CRANIOFACIAL BIOLOGY RESEARCH 
 
Overview 
Genetically engineered mice are powerful animal models used for studying 
cutting-edge craniofacial research analyzing developmental and disease states affecting 
tooth, bone and cartilage. These techniques have been well established over the past few 
decades and allow for any gene of interest to be genetically modified in a predetermined 
way based upon basic and clinical research needs. Up to the present, thousands of genes 
have been modified in mice and these mouse models are available for utilization in 
research. Importantly, many of them develop craniofacial phenotypes. These mouse 
models are created and analyzed in hope that this research will initiate translational 
approaches for enhanced understanding of human diseases and enhance subsequent 
patient treatment. This chapter will provide the basic foundation of knowledge for 
medical/dental researchers to further understand how these genetically engineered mice 
are generated, how to select specific mouse models directed towards their research 
needs, and will elaborate on the advantages and disadvantages of using different mouse 
models. 
 
 
Introduction 
The question still asked is: Why the “Mouse” as a Research Model Organism? 
The most direct answer to this question reasons that biomedical research is dependent 
upon “biological mouse models” to emphasize the genetic and physiological similarities 
between mice and humans. These mouse models have propelled craniofacial research, 
which is directed more specifically towards areas of developmental and genetic diseases 
encompassing but not limited to skull/cranial vault development and tooth/bone/cartilage 
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formation. It is the creation and characterization of these mice that has led to the 
understanding of molecular mechanisms and cellular pathways that underlie craniofacial 
development and emerging disease states (45).  
 
Major benefits of using mouse models include 
a) The most important benefit is that the mouse, like humans, is a mammal and 
has similar biochemical pathways to humans. 
b) The ease with which the mouse genome can be manipulated and analyzed.  
c) Complete genome sequencing allows for full gene studies. 
d) Being mammals, mice have immune, endocrine, nervous, cardiovascular, 
skeletal and other complex physiological systems that are similar to humans 
and therefore can be used in comparison to humans.  
e) Mice are small in size, easy to maintain, have a relatively low cost of 
maintenance and can multiply quickly – reproducing as often as every month 
(with 21 day gestation periods) 
f) Mice can be maintained well in laboratory situations and therefore can be 
controlled for environmentally (46). 
g) Inbred strains of mice are available allowing for rigorous genetic control 
within the strain but between strains genetic variation can be introduced (46). 
h) Mouse embryo developmental stages have been extensively studied and 
documented and therefore embryonic research is possible. 
i) Depending upon which mouse strain is used, mice can produce 6-15 
offspring per litter. 
j) This model organism allows for transgenic mice to be made in which any 
foreign gene of interest can be inserted into the genome. (Model organisms: 
The mouse. <http://genome.wellcome.ac.uk/doc_WTD020804.html>) 
k) Complex human diseases often result from the cumulative effects of many 
genes and these effects can be replicated well in mice using genetic 
modification techniques, which are already very well tested and utilized. For 
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example, double knockouts or triple knockouts of specified genes can be 
generated to study a certain genetic phenotype in one animal. 
l) Mice are genetically very similar to humans, and approximately 90% of 
human genes are found in mice.  
m) The rate of homologous recombination in mouse ES cells is much higher than 
that of most other cells regarding generation of genetic engineered animals. 
Currently, the reasons are not yet fully understood. 
n) There are already established mouse lines created for studying craniofacial 
development/malformation and disease. 
 
 
Terminology 
“Common Language” used in mouse model research 
Knockout (KO)  
Mice generated by the genetic manipulation of ES cells to evaluate gene function 
on the basis of the complete elimination (null allele) or partially elimination of a 
candidate gene (that is, deletion of particular domain(s) of the encoded protein). A 
specific gene locus can also be targeted and rendered non-functional by inserting within 
it a selection cassette to disrupt the expression of the encoding locus.  
 
Conditional KO (cKO)  
Mice generated to ablate a target gene at a precise time and/or within a specific 
tissue, which allows the mouse to develop to a certain stage of development prior to 
gene inactivation. This approach utilizes Cre/LoxP or Flp/FRT technologies, which are 
site-specific recombination systems. This is the main method of genetic manipulation 
used to circumvent embryonic/neonatal lethality. 
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Inducible  
Mouse models which allow for the temporal activation of genes in specific cells 
and tissues. Gene expression levels regulated by the administered agent are dosage-
dependent. Common methods used to control gene expression in these mice are based on 
the tet-operon/repressor bi-transgenic system (cell-specific and temporal-specific with 
tetracycline as the inducible agent), and the estrogen receptor (ER) ligand-binding 
domain (cell-specific and temporal-specific induction of Cre-recombinase activity with 
tamoxifen as the inducible agent) (47). 
 
Transgenic (Tg)  
Transgenic mice contain genomic modifications due to insertion of one or more 
than one copy of a piece of DNA of foreign origin (usually an exogenous gene of 
interest). Creation of these mice, which ectopically express this gene of interest, enables 
researchers to study phenotypic defects in vivo. Examples of this approach include over-
expression of a wild-type gene or expression of a dominant-negative form to diminish 
the normal function of a gene. There are a few downsides to using transgenes: 1) They 
can be relatively expensive to produce, and 2) Their expression pattern is controlled by a 
specific promoter whose activity may not fully recapture the endogenous gene levels 
regarding spatial and temporal patterning. 
 
Gain-of-function (GOF) 
“Gain-of-function” is another name for “Transgenic” and these mice are created 
to study the "gain-of-function" of a gene within the mouse. The idea is to force the 
ectopic expression of a gene during development and study its consequences; it 
addresses whether the over-expression of a gene-of-interest is sufficient to cause a 
developmental anomaly. 
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Loss-of-function (LOF) 
“Loss-of-function” is another name for “Knock-out” and these mice are created 
to study the “loss-of-function” of a gene within the mouse. The elimination of a gene in 
this “knock-out” model system has been well established in mice. 
 
Knock-in (KI)  
Mice which integrate a reporter gene, such as GFP (green fluorescent protein), 
lacZ (β-galactosidase), or luciferase, into an existing gene to visualize its temporal and 
spatial expression pattern during development in heterozygous mice, which still contain 
a normal chromosome. In homozygous mice, the knocked-in reporter will interrupt both 
chromosomes, and thus this gene will be completely interrupted, just like a classic KO 
model. In addition, this technology will allow for the specific mutation of a targeted 
gene-of-interest to examine the effects that this mutation may have on gene expression, 
gene function, and subsequent development of the mouse. These models, combined with 
knockout mouse models, may be useful in the elucidation of specific mechanism(s) 
responsible for disease pathogenesis. 
 
 
Practice and Application 
Generation of transgenic mice (Fig. 1-1) 
The common term “transgenic”, when discussing transgenic mice, describes a 
particular genetic modification to the genome in which a copy (or more than one copy) 
of a piece of DNA of foreign origin is incorporated into the genome. This causes what is 
known as “ectopic expression” of a certain gene and is an efficient method for in vivo 
mouse studies varying from over-expressing a wildtype version of a gene of interest, to 
expression of a dominant-negative form to completely diminishing the normal function 
of the gene of interest.  
Generation of transgenic mice includes three key steps: 1) generation of the 
transgene of interest (1-1A), 2) production of the transgenic mice (1-1B), and 3) 
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transgenic line screening by PCR (1-1B). In general, step two is performed by a mouse 
genetic core or a commercial company, and DNA PCR screening is a simple strict 
procedure using a pair of primers specific to the transgene. As shown in Fig.1-1B, a 
purified fragment of a transgene of interest is directly injected (by microinjection) into 
fertilized oocytes (more specifically, into the male pronucleus).  The transgene then 
randomly inserts itself into the genome of the fertilized oocytes, which are then 
implanted into pseudo-pregnant females and are brought to term. Each oocyte will 
include differential transgene expression levels which is highly influenced by positional 
effect and the overall copy number of the transgene (how many copies were randomly 
inserted) (48).  
Here we mainly focus on transgene preparation provided by the investigators 
using two different approaches, the classical transgene construct design and the BAC-
clone recombineering technique. 
 
Classical transgene construct design 
The classical transgene includes 3 main components: 5’ regulatory elements, a gene of 
interest and/or reporter gene and a poly A tail. 
The 5’ regulatory elements are required for transgene expression. These elements 
include tissue-specific promoters/enhancers or “Housekeeping gene” promoters 
(ubiquitous expression) such as chicken β-actin, cytomegalovirus (CMV) enhancer 
(CCAG or CAG promoter), or histone H4 promoter. In general, the promoter size is 
limited due to cloning difficulties. 
The gene of interest and/or reporter gene includes a mini gene (containing both 
exons & introns), cDNA (lacking introns), anti-sense RNA (for blocking a gene of 
interest), or report genes (for tracking expression levels of the gene-of-interest). There 
are many reporter genes, but a few of the common reporter genes are: LacZ (from E. 
coli, encoding β-galactosidase), which can be visualized using histochemical (X-Gal 
staining) or immunocytochemical methods at single cell level which is particularly 
useful for cell-lineage tracing and defines Cre activities (see Section 3 for details). The 
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disadvantage of using this reporter is that it is less sensitive with a longer half-life. 
Another common reporter gene is luciferase (from the Firefly), which is extremely 
sensitive and particularly useful for quantifying expression levels but homogenization of 
the tissue is necessary for any analyses to be performed. Another set of common reporter 
genes includes the fluorescent proteins. These proteins are very sensitive, easily 
visualized, no substrates required, analysis performed in live tissue, isolation of cells 
using FACS, with different fluorophore colors: EGFP (green, from jelly-fish), EYFP 
(yellow), ECFP (cyan), and RFP (red, from reef coral). In particular, RFP is now very 
popular and there are different variants (such as DsRed and tdTomato). These new 
proteins have longer wavelengths, lower background, increased brightness and photo-
stability. In addition, specific mono/polyclonal antibodies against DsRed-Express are 
available and they do not cross-react with EGFP and can be used for 
immunohistochemical analysis (see an example in Fig. 1-1C). 
SV 40 PolyA sequences (poly A tail) are widely used for stabilizing the transgene 
for its translation in the cytoplasm.  
 
Construction of the transgenic construct is amplified in bacteria using restriction 
enzymes and DNA ligases, and the final construct has to be released from the rest of the 
vector and purified. There are several limitations in building a construct via these 
methodologies. As a result, a new cloning technique has been developed: 
Recombineering (see below). 
 
BAC-clone recombineering technique  
Recombineering is a highly efficient method for genetically modifying DNA 
within E.coli and other bacteria. This technique incorporates in vivo homologous 
recombination-mediated genetic engineering and produces gene replacements, deletions, 
insertions, inversions, duplications and single and multiple point mutations, fusions and 
tags. Recombination, using this method, occurs efficiently with relatively short 
sequences of homology, and allows the recombinant DNA to be generated in vivo. A 
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benefit to recombineering is that it does not rely on restriction enzymes or DNA ligases 
in contrast to other genetic engineering methods. There are systems that are utilized 
within the bacteria and these are based on controlled expression of proteins that permit 
homologous recombination through homologies as small as 42 bp in size. The 
recombination proteins in these systems are inducible, meaning that they are transiently 
expressed to permit recombination and are not constitutively expressed. Recombinant 
clones are engineered to include a selective cassette such as antibiotic resistance for both 
positive and negative selection. 
Bacterial Artificial Chromosome (BAC) transgenic mice express a variety of 
reporters, epitope tagged-proteins or Cre recombinase driven by specific promoters. A 
major benefit to the use of BAC cloning is that BAC’s contain several hundreds of 
thousands of base pairs of regulatory sequences. These sequences act to regulate the 
endogenous genes more effectively than the shorter transgenes making BAC cloning an 
effective cloning system. In bacteria, such as E. coli, the BAC can easily undergo 
homologous recombination with a vector that has inserted into it the gene-of-interest 
between two homologous regions of the BAC. After homologous recombination occurs, 
the BAC will include the gene-of-interest cassette. This BAC is then microinjected into 
an oocyte. The oocyte is implanted into a pseudo-pregnant female mouse and the mice 
(approximately 20-30% of the offspring) that have incorporated the engineered DNA 
sequence, called “founders”, are then backcrossed with wildtype mice. Of these new 
offspring, approximately 50% of them will inherit the BAC. 
 
Conventional KO mouse model 
A conventional KO mouse model is one in which a targeted gene or genetic 
region has been completely eliminated (ablated) creating a null allele, or has been 
functionally disrupted usually by partial elimination of the candidate gene – deletion of a 
particular domain of the gene important for functional activity (48). This can be carried 
out by either inserting a selection cassette (ex: neomycin-resistance) or a specific 
reporter gene (for tracing the expression pattern of the targeted gene) such as GFP or 
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lacZ into the gene locus. Deleting a gene in this manner yields a mouse model lacking 
the functional targeted gene. The production of a null allele causes gene ablation in all 
cells within the body and has been shown to be a very valuable approach in determining 
in vivo gene functions.  
 
Creating a KO mouse (Fig. 1-2) 
The construction of a conventional genetically modified knockout mouse 
requires the design and use of a targeting vector. Construction of the targeting vector 
will allow for either complete gene removal (gene ablation) or a specific exon is selected 
for removal that will disrupt the protein product for that gene. It is common for the 
construct to carry a selectable marker (such as a kanamycin/neomycin resistance gene) 
and for two regions of homology of the target gene to flank either end. 
The targeting vector is introduced into a specific ES cell line such as 129Sv/EV 
ES cells, which will generate mice with a brown coat color. Electroporation is used to 
introduce the targeting vector into the ES cells and then these cells are plated out under 
optimal conditions for growth. 
The ES cells are put through rigorous positive and negative selection methods to 
select for only those ES cells that have taken up the targeting vector through 
homologous recombination, in which nucleotide sequences are exchanged between the 
endogenous DNA and a very similar DNA fragment (the targeted DNA construct). A 
common method is to incorporate a neomycin resistance cassette into the gene area of 
interest within targeting vector (used for positive selection), and a TK (thymidine kinase) 
gene cassette placed outside the region of homology (used for negative selection). The 
neomycin cassette responds positively to administration of G418 (those cells that have 
not incorporated the neomycin cassette will die) and the TK cassette responds negatively 
to administration of Gancyclovir (those cells which have the incorporated TK cassette 
will die). 
After the selection procedure, those ES cells that are left should theoretically be 
positively targeted cells. Due to the nature of a random incorporation of the targeted 
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gene construct into a chromosome, only one homologous recombination event occurs in 
each cell with approximately a 1% probability. Thus, more than 300 clones need to be 
screened in order to obtain one or possibly a few ES cells, which have undergone 
homologous recombination. Each positive clone is plated in two wells on separate 96-
well plates and one set of the ES clones is frozen down while the other set is used for 
confirmation of correct homologous recombination via PCR and Southern Blot methods. 
Once the positive clones have been identified, the second set of frozen clones is 
thawed, allowed to expand in culture and then used for blastocyst injection into 3.5-day-
old mouse blastocysts, which are obtained from a different mouse strain such as C57/B6 
mice with a black coat color. 
A foster mother is chosen for uterine implantation of the blastocyst, and she is 
considered a pseudo-pregnant female as pregnancy is induced by mating her with a 
vasectomized male. The stimulus of mating elicits the hormonal changes needed to make 
the female mouse’s uterus receptive. 
The foster female mouse is allowed to come to term and among the mice that are 
born, there is the possibility for pure wildtype (WT) mice (black coat color), or chimeric 
mice that have a mixed genetic background (mixed black and brown coat colors). The 
cells in the chimeric mice come from two resources: the blastocyst (ex. C57/B6) and the 
engineered ES cells (ex. 129Sv/EV).  
Male chimeric mice are then crossed back to female WT mice (black coat color) 
and then this backcross should give rise to mice that are heterozygous for the targeted 
allele (brown coat color, i.e. the entire genetic information comes from the engineered 
ES cell). These mice are then interbred to produce a homozygous gene targeted mouse.  
It is important to understand that the reason that ES cells are used in producing 
gene targeted mice is because ES cells are considered pluripotent, meaning that they 
have full potential to give rise to any cell type within the body. A major problem for 
many transcription factors with this knockout approach is embryonic lethality whereby 
the neonates die prior to birth (usually during a critical developmental stage in which 
that gene is necessary for vitality). To circumvent this issue, a new genetic engineering 
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technique was developed which utilizes Cre/LoxP or Flp/Frt technologies (described 
later).  
 
Knock-in (point mutation, reporter genes, and cre) 
Knock-in mice are a powerful research model for all fields of research, including 
bone and craniofacial, and have multiple different uses. The knock-in method is also 
known as the exogenous gene introduction method in which anon-mouse gene is 
engineered into the genome and the protein functions of this specific gene are then 
analyzed. Usually, the ectopic gene is introduced at a specific gene locus, but it is also 
possible to introduce it in a form that disrupts the homologous gene in the mouse. 
Another term for the latter disruption method is called the knockout/knock-in method as 
one gene is being knocked out (ablated) due to another gene being expressed in its place, 
plus the gene structure is interrupted (see example presented in Fig. 1-3).  
The most common uses of the knock-in mouse model:  
Humanization: replaces a mouse gene with its human counterpart – could be a 
portion of the human gene or an entire gene. The human protein is then expressed under 
the mouse promoter and regulatory regions and it is a great model for studying the 
function of a specific gene in disease models. 
Point Mutation: Using the knock-in method, it is also possible to introduce a 
point mutation into the sequence of a gene-of-interest causing the mouse to express a 
mutant protein instead of the wildtype protein. The mutation may cause abnormal 
protein function (a method to test protein functional domains) but it should not alter the 
expression pattern of the protein. The point mutation can be introduced as either a direct 
mutation or an inducible mutation (temporal- or tissue-specific). A great benefit to using 
this approach is that a point mutation model can be used in place of a knockout mouse 
model that causes embryonic lethality. 
Reporter/Tag: This method introduces a reporter gene, such as LacZ, GFP, 
mCherry, YFP or DsRed, into the locus of a target gene in order to monitor the 
expression of that gene at the transcriptional level.  
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Conditional knockout mouse models 
Conditional knockout mice are highly important in gene studies due to their 
ability to eliminate a gene-of-interest in a temporal- and tissue-specific manner. Due to 
the fact that the ablation of certain genes causes embryonic lethality, this model is 
utilized to circumvent this pertinent issue. The two major systems developed within the 
conditional knockout model are the Cre-Lox system and the Inducible system. 
 
Cre-Lox system 
The Cre-lox system was developed to facilitate the production of conditional 
knockout and reporter strain animal models. This method has been perfected in mice and 
is a widely used method of genetic manipulation in embryonic stem cells using site-
specific DNA recombination through the interaction of a Cre-recombinase enzyme and 
LoxP sites to delete the gene in specific targeted tissues. The system was originally 
discovered in the P1 bacteriophage, which uses the innate Cre-lox recombination method 
to circularize and facilitate replication of its genomic DNA when reproducing (49). The 
use of this model also allows for gene deletion in the mature, adult mouse and is an 
alternative to studying gene expression embryonically (Figs. 1-4,5).  
 
Craniofacial biology Cre-expressing mouse models 
 Different promoter-expressing Cre-recombinase mouse lines are known to be 
expressed in osteoblasts and chondrocytes and their progenitor cells (tables i & ii).  
Paired-related homeobox gene-1 (Prx1) is expressed in the early mesenchymal 
condensations that form the developing limbs and parts of the skull in the mouse, and 
has been well established to have a pertinent role in skeletal development (50, 51). Prx1-
Cre has been shown to decrease RANKL in the calvaria and the developing limb when 
crossed with RANKL floxed mice (51) and caused short limbs, an open sternum and an 
open skull in TGFβR2 floxed mice crossed with Prx1-Cre mice (52). Prx1-Cre mice are 
readily available for purchase from Jax laboratories. The transcription factor Sox9 is 
expressed in osteo-chondroprogenitor cells and has a pertinent role in chondrogenesis 
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and endochondral bone formation. Sox9 activates chondrocyte-specific marker genes, 
such as Col2a1, Col11a1 and Aggrecan and severe chondrodysplasia develops if Sox9 is 
inactivated during or after mesenchymal condensation (53). Sox9 has also been shown to 
be highly expressed in proliferating chondrocytes in the condyle at E16.5 and has a 
crucial role in cartilage development. A study which ablated Smo (a positive effector in 
the Hedgehog signaling pathway) in chondrocyte progenitors when crossed with 
Sox9Cre, results in the normal formation of the condylar disk, but a failure of the disk to 
separate from the condyle itself (54). Information on this mouse model is available at Jax 
Laboratories and the International Knockout Mouse Consortium. Type II collagen, a 
major component of cartilaginous extracellular matrices, is highly expressed during 
chondrocyte differentiation (55). Osterix (Osx) Cre mice (OsxCre) is an tetracycline-
inducible mouse line and has a GFP/Cre fusion protein active under the Osterix (Sp7) 
promoter (56). A recent study has shown that this mouse model actually has a phenotype 
itself at skeletally mature stages and in the absence of doxycycline administration before 
12 weeks of age, it will display delayed growth. A second type of OsxCre mice is 
OsxCreERT2 which is tamoxifen-inducible and allows for the temporal induction of its 
activity and has been used for osteoblast lineage tracing in vivo (57).  
 The rat 2.3-kb Col1a1 promoter has been shown to be active in mature 
osteoblasts and odontoblasts. The temporal- and site-specific Cre/loxP system was used 
under the 2.3-kb Col1a1 promoter to inactivate Osx in osteoblasts (58). A 2.3-kb 
Col1a1-CreERT2 is also available and inducible Cre recombinase activity is shown to be 
detected in E18.5 and Day-18 long bone (limb) osteoblasts, ribs, vertebrae and calvaria 
(positive activity tested as these two time points) (Ref: Jax Laboratories 
<http://jaxmice.jax.org/strain/016241.html>). 2.3-kb Col1a1-Cre and 3.6 Kb Col1a1-Cre 
mice were bred to ROSA26 (R26R) mice to detect β-galactosidase expression evident in 
osteoblasts and for 3.6 kb promoter-driven Cre recombinase it was expressed in the bone 
marrow cells.  
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Common Cre lines for bone/tooth tissue (Ex: osteoblasts/odontoblasts/pulp cells) 
 
 
Common Cre lines for cartilaginous tissue (Ex: chondrocytes) 
 
Common Cre lines for osteoclasts 
 Osteoclasts are terminally differentiated cells that attach to the bone and 
secrete proteases, the primary protease of the organic component being Cathepsin K, 
which degrades the boney matrix.  A common Cre-recombinase mouse line used for 
research in Osteoclasts is Cathepsin K-Cre (CtsK-Cre), which has been shown to delete 
the gene-of-interest in mature osteoclasts (59, 60). Another main Cre line specific to 
osteoclasts is the tartrate-resistant acid phosphatase (TRAP)-Cre. This Cre has been 
analyzed and shown to be active in long bones, vertebrae, ribs and calvaria but more 
specifically in osteoclasts (Ctsk-Cre and TRAP-Cre lines) and columnar proliferating 
and hypertrophic chondrocytes (TRAP-Cre line only) (61). 
Cre Mouse Line Promoter Cell Type Activity
Prx1Cre Paired-related Homeobox 1 Mesenchymal Progenitor Cells
Sox9Cre Sox9 Chondroprogenitor Cells
Col2a1Cre Collagen 2 α1 chain Chondroprogenitor Cells
Col2a1ERT2 Collagen 2 α1 chain Chondroprogenitor Cells
Col2a1ERT2 Collagen 2 α1 chain Committed Chondrocyte
Agc1ERT2 Aggrecan Committed Chondrocyte
Col10a1 Collagen 10 Hypertrophic Chondrocyte
OcCre Osteocalcin Mature Osteoblast
Cre Mouse Line Promoter Cell Type Activity
Prx1Cre Paired-related Homeobox 1 Mesenchymal Progenitor Cells
Sox9Cre Sox9 Osteoprogenitor Cells
Col2a1Cre Collagen 2 α1 chain Osteoprogenitor Cells
OsxCre Osterix Osteoprogenitor Cells
OsxCreERT2 Osterix Osteoprogenitor Cells
Col1a1 3.6kb Cre Collagen 1 α1 chain Osteoprogenitor Cells
Col1a1 3.2kb (CreERT2) Collagen 1 α1 chain Inducible-Cre for Osteoblast at any stage
Col1a1 2.3kb Cre Collagen 1 α1 chain Committed Osteoblast
OcCre Osteocalcin Mature Osteoblast
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Common Cre lines for ameloblasts 
 A common Cre line used for studying gene expression in ameloblasts is K14-
Cre and it has been verified in a study of conditional knockout (cKO) mice containing 
floxed p120 and the Cre recombinase linked to the keratin-14 promoter (K14-Cre p120-
cKO) (62). Another study analyzed the role of FGFR1 in enamel and tooth development 
utilizing the K14-Cre mouse line demonstrating that there is a cell-autonomous 
requirement for FGF signaling in the dental epithelium during enamel formation (63). 
 
Inducible systems 
 The inducible transgenic mouse model is an effective biological model for 
the temporal activation of a gene-of-interest in specific cells and tissues (for example, 
only within osteoblasts, ameloblasts or odontoblasts etc.). Expression levels are dosage-
dependent (of the agent administered). There are certain advantages and disadvantages 
of using this system, which are important to understand before utilizing this method for 
research studies. Some of the more significant advantages include: 1) the ability to 
bypass issues with embryonic lethality within a specific genetic manipulation (seen in 
conditional knockout and conventional knockouts), 2) the fact that inactivation of a 
gene-of-interest can be studied at specific time points during different stages (in utero) 
during development or postnatally, and 3) the ability to induce the inactivation at any 
time point allows for the study of age-specific diseases. A major disadvantage of using 
this system is that endogenous gene deregulation or truncated protein expression can 
occur if a thorough analysis of the selected gene of interest and surrounding genetic 
material is not performed.  
The two most widely used systems for inducible control of gene expression are 
the Tet-operon/repressor bi-transgenic system (tetracycline (Tc)-regulated) and the 
Estrogen Receptor (ER) ligand-binding domain system. (Cre-ER). 
The tetracycline-regulated transgenic models are typically designed to activate 
the expression of the gene of interest in a temporal and tissue-specific manner. When the 
transgenic mouse carrying a Tc-regulated transactivation factor (put under a promoter of 
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choice) is mated with a mouse carrying a minimal promoter driving the expression of a 
specific gene-of-interest, the resultant offspring inheriting both transgenes can be treated 
with doxycycline and will then express the gene of interest. The treatment of 
doxycycline is the temporal control mechanism and the promoter of choice regulates the 
tissue-specificity. 
The Estrogen Receptor (ER) ligand-binding domain system is a tamoxifen-
inducible system which utilizes a fusion protein between Cre and a mutated form of the 
ligand binding domain of the estrogen receptor (Cre-ERTM) that renders Cre activity 
tamoxifen (TM) inducible, allowing for conditional modification of gene activity in the 
mammalian neural tube in utero(64). The ER can also be fused to proteins other than 
Cre, such as transcription factors or kinases that are active in the nucleus. Cre can either 
be used to activate gene expression by removing stop cassettes from transgenes which 
are flanked by LoxP sites, or inactivate gene expression by removing the gene-of-interest 
flanked by LoxP sites (see example presented in Fig. 1-6). 
These two systems are complementary in mouse models, being effective in cell-
specific activation and inactivation of gene expression (47). 
 
 
Discussion 
 By five years of age, approximately two to three percent of all infants and 
children are found to have craniofacial birth defects, and of the 6000 known hereditary 
syndromes, over 700 have either dental or craniofacial associated defects, and over 250 
syndromes have associated clefting (65). The incorporation of genetically engineered 
mice into our research fields of interest (such as within the craniofacial and bone fields) 
has greatly improved and furthered our understanding of a variety of human 
development and disease states and will continue to aid in the development of many 
therapeutic approaches. 
 Prior to the use of mouse models, our understanding of the complexity of the 
human/mouse genome was still in its infancy. It wasn’t until gene technology advanced 
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in mice that researchers were able to fully understand the complexity of these genes and 
how certain genes interact to produce a defined disorder/disease. 
Mouse models have been utilized extensively to distinguish between genetic and 
environmental stimuli on craniofacial disorders. These models are important in 
diseases/abnormalities such as cleft lip and palate, tooth anomalies and cranial 
vault/skull malformations. Human craniofacial disorders are able to be recapitulated in 
the mouse and can be studied on a very intricate level which will ultimately lay the 
foundation for advancements in therapies. 
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CHAPTER III 
POSTNATAL EFFECT OF OVEREXPRESSED DKK1 ON 
MANDIBULAR MOLAR FORMATION* 
 
Overview 
Dickkopf-related protein 1 (Dkk1) is a potent inhibitor of Wnt/β-catenin 
signaling. Dkk1-null mutant embryos display severe defects in head induction. 
Conversely, targeted expression of Dkk1 in dental epithelial cells leads to the formation 
of dysfunctional enamel knots and subsequent tooth defects during embryonic 
development. However, its role in post-natal dentinogenesis is largely unknown. To 
address this issue, we studied the role of Dkk1 in post-natal dentin development using 
2.3-kb Col1a1 Dkk1-transgenic mice, with the following key findings: (1) The Dkk1 
transgene was highly expressed in pulp and odontoblast cells during post-natal 
developmental stages; (2) the 1st molar displayed short roots, an enlarged pulp/root canal 
region, and a decrease in the dentin formation rate; (3) a small malformed second molar 
and an absent third molar; (4) an increase of immature odontoblasts, few mature 
odontoblasts, and sharply reduced dentinal tubules; and (5) a dramatic change in Osx 
and Nestin expression. We propose that Dkk1 controls post-natal mandibular molar 
dentin formation either directly or indirectly via the inhibition of Wnt signaling at the 
following aspects: (i) post-natal dentin formation, (ii) formation and/or maintenance of 
the dentin tubular system, (iii) mineralization of the dentin, and (iv) regulation of 
molecules such as Osx and Nestin. 
 
 
 
 
                                                
* Reprinted with permission from “Post-natal effect of overexpressed DKK1 on 
mandibular molar formation” by XL Han, A Voisey, et al., 2011. J Dent Res, 90, 1312-
7, Copyright [2011] by International & American Associations for Dental Research. 
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Introduction 
Tooth formation begins with a series of reciprocal signaling interactions between 
the stomodeal ectoderm and the underlying neural-crest-derived ectomesenchyme (66). 
The first sign of tooth formation is the thickening of the oral epithelium. This is followed 
by the invagination of the epithelium into the underlying mesenchyme, which then 
condenses and forms a tooth bud. In the past two decades, many signaling molecules and 
transcription factors which are critical for these processes have been identified (66-69). 
However, critical factors required for tooth root formation, which occurs mainly post-
natally, are largely unknown. 
It is known that Wnt/β-catenin signaling in the dental epithelium is critical for 
dental patterning during multiple stages of early tooth development. The supportive 
evidence is that constitutive activation of β-catenin in the epithelium causes the 
formation of large malformed tooth buds and ectopic teeth (18). Alternatively, blocking 
Wnt/β-catenin signaling by the targeted expression of Dkk1 in epithelial and underlying 
mesenchymal cells led to the formation of blunted molar cusps (i.e., blocking the 
secondary enamel knots) (18). The role of Wnt signaling in the dental mesenchyme 
during tooth patterning is controversial. Chen et al. showed that the inactivation of β-
catenin resulted in tooth arrest at the bud stage in both molars and incisors (19). In 
contrast, a new report showed that the genetic inactivation of β-catenin results in a 
splitting of the incisal placode. This inactivation forms 2 incisors per incisal placode in 
the lower jaw in approximately 50% of all mutant embryos (70). 
Recently, Lohi et al. showed that Axin2 lacZ signal, which reflects the canonical 
Wnt signaling pathway, is expressed in dental pulp and developing odontoblast cells, but 
not in ameloblast cells post-natally (20), suggesting a potential role for canonical Wnt 
signaling in post-natal tooth formation. 
Dkk1 (a secreted protein with 2 cysteine-rich domains, separated by a linker 
region) is expressed in the tooth and the limb during development (16, 71-73). 
Suomalainen and Thesleff showed that Wnt/β-catenin activity and Dkk1 mRNA were 
detected in incisor mesenchyme (74). Dkk1 functions as an antagonist of canonical Wnt 
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signaling through two mechanisms: (1) by binding to the Lrp5/6 co-receptor to prevent 
its interaction with Wnt-Frzd complexes; and (2) by binding to the cell-surface receptor 
Kremen1 or Kremen 2 to promote the internalization of Lrp5/6 (75). Injections of Dkk1 
mRNA result in head induction in Xenopus embryos (76), and deletion of Dkk1 leads to 
embryonic lethality with no anterior head structures in addition to exhibiting limb 
defects (77). Ectopic expression of Dkk1 in K5-expressing epithelium blocks taste 
papilla development, causing a lack of innervation of the tongue (78). 
Although Dkk1 mRNA is expressed in the dental papilla, pre-odontoblasts, and 
odontoblasts (16), its function in post-natal tooth root formation is largely unknown. In 
this study, we attempted to address the function of Dkk1 in post-natal dentin formation 
using 2.3-kb Col1a1 Dkk1-transgenic (Tg) mice (13) and multiple approaches, including: 
radiography, µ-CT, histology, TRAP staining, immunohistochemistry, double-
fluorochrome labeling for measuring dentin formation rates, and scanning electron 
microscopy (SEM) for determining dentin properties. Our results demonstrate that 
overexpression of Dkk1 in pulp and odontoblast cells impaired mandibular molar dentin 
formation, suggesting that Dkk1 plays an active role in post-natal tooth formation either 
directly or indirectly through the Wnt/β-catenin signaling pathway. 
 
 
Experimental Procedures 
Generation of 2.3-kb Col1a1-Dkk1 transgenic mice 
All animal studies were reviewed and approved by the Institutional Animal Care 
and Use Committee at the institute. The 2.3-kb Col1a1 Dkk1-Tg mice were generated as 
described previously (13). A C57/B6 strain background was used in this study. The 
genotypes of the mice were determined by PCR analysis of genomic DNA extracted 
from tail biopsies. For the Col 1a1 Dkk1-transgene, the forward primer, 5′-
CATCCCTGTGACCCCTCC-3′, and the reverse primer, 5′-
CTCCAAACCACCCCCCTC-3′, were used to generate a PCR product of 150 bp. 
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Sample preparation and histological analyses of Dkk1 expression 
Mandibular samples obtained from E16.5, P01, 1-week-, and 1-month-old mice 
were fixed in 4% paraformaldehyde in 4ºC overnight. These samples were then 
decalcified with 10% EDTA in a microwave, dehydrated, and embedded in paraffin. 
They were then sectioned (4-µm thick) and used in immunohistochemistry for Dspp 
(polyclonal antibody was kindly provided by Dr. Larry Fisher from NIDCR, National 
Institutes of Health, Bethesda, MD, USA), Dkk1 (polyclonal antibody, R&D Systems, 
Minneapolis, MN, USA), Osx (osterix monoclonal antibody, Abcam, Cambridge, MA, 
USA), Nestin (mouse monoclonal antibody, Santa Cruz, CA), and TRAP (tartrate-
resistant acid phosphatase) staining. Finally, the slides were mounted with permount, 
and photographed under by light microscopy. 
 
Analysis of dentin formation rate by double-labeling and imaging resin-cast odontoblast 
processes by scanning electronic microscopy (SEM) 
To examine the dentin formation rate, we performed double-fluorescence 
labeling as described previously (79). Briefly, a calcein label (5 mg/Kg i.p.; Sigma-
Aldrich, St. Louis, MO, USA) was administered to 20-day-old mice, followed by 
administration of calcein 7 days later. Mice were sacrificed 2 days after the second 
injection (1 mo old). The non-decalcified mandibles were embedded in resin 
(methylmethacrylate, MMA), sectioned, and photographed under epifluorescent 
illumination with a Nikon 800 microscope (Nikon, Melville, NY, USA). Furthermore, 
the surface of the same blot was polished with different diamond suspensions until 
smooth and scratch-free before being acid-etched and imaged by SEM as described 
previously (80). The surface was acid-etched with 37% phosphoric acid for 2 to 10 sec, 
washed twice with water followed by 5% sodium hypochlorite for 5 min, and washed 
again with water. After being air-dried, the samples were coated with gold and 
palladium, and examined by FEI/Philips XL30 Field emission environmental SEM. 
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Radiograph and micro-ct imaging of mandibles from 1-month-old Dkk1-Tg mice 
Both the wild-type and Dkk1-Tg mandibles were radiographed with a Faxitron 
model MX-20 System (Faxitron X-Ray LLC, Lincolnshire, IL, USA), and scanned with 
a Micro-CT 35 (Scanco Medical AG, Bassersdorf, Switzerland). 
 
 
Results 
The 2.3-kb Col1a1-Dkk1 transgene is highly expressed in odontoblasts and pulp cells 
To determine whether Dkk1 plays a role in odontogenesis, we first compared the 
Dkk1 expression patterns during dentinogenesis in WT and Dkk1-Tg mice starting from 
E16.5. Analysis of the immunohistochemical data from E16.5 molars showed that Dkk1 
is largely undetected in both WT and Tg odontoblasts (Fig. 2-1A). Dkk1 was weakly 
expressed in WT newborn odontoblasts (Fig. 2-1B, left panel), but had a much higher 
expression level in newborn Dkk1-Tg pulp cells and odontoblasts within the molars at a 
low antibody concentration (Fig. 2-1B, right panel; 1:100 dilution). Higher expression 
levels were also observed in pulp and odontoblast cells of Dkk1-Tg 1-week old 
mandibular molars (Fig. 2-1C). A weak Dkk1 signal was detected in osteoblast cells, but 
a much higher level of Dkk1 was detected in Tg osteoblasts (Fig. 2-1D). A clear Dkk1 
signal was detected in newborn and 1-week WT pulp, odontoblast, and ameloblast cells 
at a high antibody concentration (Fig. 2-5). 
 
The 2.3-kb Col1a1-Dkk1 transgenic mice display a striking molar phenotype in the 
mandible 
To address whether overexpression of Dkk1 in mesenchymal cells changes the 
tooth phenotype, we first screened mandibular samples using x-ray and µCT (Fig. 2-2A). 
Unexpectedly, the 3rd molar in all Dkk1-Tg mice was missing in mice examined at the 
age of 2 wks (Fig. 2-6A) and 4 wks (Fig. 2-6B). The radiograph and µ-CT images 
obtained from the 1st molar also showed a malformed crown, which is reduced in size 
and has short roots and an enlarged pulp/root canal region. The 2nd molar is much 
  34 
smaller than that in the age-matched control (Fig. 2-2A, right panels). Analysis of 
quantitative data showed that reduction of the full tooth, the root length, the ratio of 
tooth root/full tooth length, and dentin thickness in the Dkk1-Tg 1st molar is significant 
(Fig. 2-2B). 
Since the tooth root is embedded in alveolar bone and the Dkk1-transgene is 
targeted to the osteoblast cells (Fig. 2-1D), we next asked whether there is an alveolar 
bone phenotype that could be responsible for the tooth phenotype observed within the 
Dkk1-Tg mice. There is mild bone loss in the Dkk1-Tg mice, shown by µCT and H&E 
staining assays (data not shown), although it is very unlikely that bone loss is the major 
cause of such a severe tooth phenotype. 
To determine whether the overexpression of Dkk1 changes the dentin 
ultrastructure, we next examined the first mandibular molar by SEM using an acid-
etched resin-casting technique (Fig. 2-2C). When comparing the Dkk1-Tg first molars 
with the age-matched controls, we observed striking differences in the appearance of the 
dentin tubules, with the tubular processes being sharply reduced and disorganized. 
Analysis of quantitative data showed a significant reduction of dentinal tubule number in 
Dkk1-Tg mice (Fig. 2-2C, middle panel). We also measured the dentin apposition rate 
using a fluorochrome labeling assay (81). The distance between the 2 fluorochrome-
labeled lines was used to calculate the dentin formation rate and was shown to be 
significantly reduced in the Dkk1-Tg mandibular molars (> 20%, Fig. 2-2D). 
The above data indirectly reflect a critical role of Wnt/β-catenin signaling during 
post-natal molar dentin formation. 
 
The 2.3-kb Col1a1-Dkk1 transgenic mice exhibit dentin erosion and expanded 
periodontal ligament (PDL) 
As the striking tooth phenotype is displayed in the mandibular molars at 1-month 
of age, we further characterized the dentin phenotype using backscattered SEM imaging, 
which displayed numerous areas of dentin erosion in the Dkk1-Tg mice (Fig. 2-3A, right 
panel). To address the cause of dentin erosion, we re-examined Dkk1 expression in the 
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first molar. Unexpectedly, Dkk1 was detected in the PDL cells and the acellular matrix 
with the area of dentin erosion, which was filled with many cells (Fig. 2-3B, right 
panel). Since the osteoclast is the only cell that can resorb the mineralized tissue, we 
next examined the presence of osteoclast cells using a TRAP staining assay. The results 
showed that overexpression of Dkk1 significantly increased osteoclast numbers (Figs. 2-
3C, 2-3D right panels). We also showed that there were few acellular cementoblasts in 
the Dkk1-Tg mice (Figs. 2-3B, 2-3C right panel), and the µCT image displayed an 
expanded PDL region (Fig. 2-3E, right panel). Analysis of these data, taken together, 
supports the notion that dentin erosion is caused by two factors: an increase in osteoclast 
number and a defect in acellular cementoblasts within Dkk1-Tg mice. 
 
Overexpression of Dkk1 delays the maturation of dentinogenesis during post-natal 
development 
To study the mechanism by which the targeted overexpression of Dkk1 leads to 
the above dentin structural changes, we investigated the expression patterns of Osterix 
(Osx), a transcription factor which is critical for tooth formation (79), and Nestin, a 
specific marker for odontoblasts reflecting its neural-crest derivation (82, 83). Analysis 
of immunohistochemical data showed that Osx was mainly expressed in the nucleus of 
odontoblasts of WT molars (Figs. 2-4A, 2-4B left panels). Conversely, Osx was 
expressed in a much broader array of cells, including later pulp cells and early 
odontoblasts, and the Dkk1-Tg molars lacked a defined polarized odontoblast layer (Fig. 
2-3C and Fig. 2-8, right panels). In addition, analysis of Nestin antibody staining data 
revealed a sharp reduction of Nestin expression levels in Dkk1-Tg odontoblasts (Fig. 2-
4C, right panel). Analysis of these data suggests that Dkk1 regulates Osx and Nestin in 
post-natal dentin formation, and that the changes of these molecules could be partly 
responsible for the immature odontoblast phenotype in the Dkk1-Tg mice. 
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Discussion 
Dkk1, primarily expressed in mesenchymal-derived tissues such as the dental 
papilla, pre-odontoblasts, and odontoblasts during tooth development, is speculated to be 
important for dental patterning and crown morphology (16). In this study, we directly 
targeted Dkk1 overexpression in pulp odontoblasts to investigate its specific role during 
post-natal tooth (particularly root) development in vivo. Our main findings are: (1) The 
Dkk1-transgene, driven by the rat 2.3-kb Col1a1 promoter, whose activity is observed in 
both pulp (low level) and odontoblast (high level) cells (84) (Fig. 2-9), is mainly 
expressed in post-natal pulp and odontoblast cells; (2) Dkk1-Tg mandibular molars 
display a severe post-natal phenotype, including short roots, an enlarged pulp/root canal 
region, thin dentin, a considerable reduction in the dentin formation rate, a small 
malformed second molar, and an absent third mandibular molar; and (3) changes of Osx 
and Nestin expression in odontoblast cells, an increased number of immature 
odontoblasts, few mature odontoblasts, and a sharply reduced dentinal tubule number. 
Thus, we propose that Dkk1 controls post-natal mandibular molar dentin formation 
either directly or indirectly via inhibition of Wnt signaling in the following levels: (i) 
post-natal dentin formation, (ii) formation and/or maintenance of the dentin tubular 
system, (iii) mineralization of the dentin, and (iv) regulation of molecules such as Osx 
and Nestin. 
The actual role of Wnt/β-catenin or Dkk1 in post-natal tooth (especially root) 
formation is not clear, since previous work mainly focused on tooth germ and crown 
formation during embryonic development. In this work, we directly target Dkk1 in pulp 
and odontoblast cells during the post-natal developmental stage. Analysis of our data 
clearly showed a striking dentin phenotype (see above), suggesting that Wnt/β-catenin 
signaling continuously plays a key role during post-natal dentin formation. Interestingly, 
the 2.3-kb Col1a1 Dkk1-transgene is active in pulp and odontoblast cells, while there is 
no sign of the 3rd mandibular molar in all Dkk1-Tg mice examined by radiograph, with 
6 samples at the age of 2 wks and 6 samples at the age of 4 wks (Fig. 2-2). With an H&E 
staining assay, we noticed an empty cavity within the Dkk1-Tg mandibular alveolar bone 
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where the 3rd molar should be (data not shown), suggesting that the tooth germ was 
formed but its growth was arrested and then it was subsequently resorbed. Thus, we 
speculate that the high level of Dkk1 released from pulp cells either directly or indirectly 
(through the inhibition of Wnt/β-catenin signaling) blocks further development of the 
3rd molar. At this stage, we do not know whether this inhibitory role is Wnt/β-catenin-
dependent or –independent, or both. Future generation of an odontoblast-specific Dkk1 
knockout animal model would yield a clearer picture of the roles of Dkk1 in post-natal 
tooth development. In addition, we plan to cross the 2.3-kb Col1a1 Dkk1-Tg mice to the 
Top-Gal mouse line (85), to determine whether lacZ expression, which reflects Wnt/β-
catenin signaling, is altered in the Dkk1-Tg tooth. 
Tooth, unlike bone, is usually not resorbed by osteoclasts, likely because of the 
presence of anti-resorption factors residing in the PDL region and an intact acellular 
cementoblast layer for its protection (86). Here we showed severe dentin resorption on 
the Dkk1-Tg root surface (Fig. 2-3). This defect is most likely caused by an increase in 
osteoclast numbers and a defect in the acellular cementum. It is known that Wnt 
signaling up-regulates Opg in the mature osteoblast, which blocks Rankl-induced 
osteoclastogenesis (87). Overexpression of Dkk1 will increase osteoclast numbers via an 
inhibition of Wnt signaling. 
In contrast to the severe tooth phenotype observed in the mandibular molars (Fig. 
2-2), the maxillary molar phenotype is mild (Fig. 2-7); suggesting that regulation of 
tooth patterning is complex. Similar variation in tooth phenotype within other genetic 
animal models has also been reported. For example, Thomas et al. demonstrated that 
null mutations of both Dlx-1 and Dlx-2 homeobox genes display no maxillary molars, 
while the incisors and the mandibular molars develop normally (88). Denaxa et al. 
showed that a double knockout of homeodomain transcription factors Lhx6 and Lhx7 
leads to molar agenesis, with incisors being largely unaffected (69). 
In summary, 2.3-kb Col1a1 Dkk1-transgenic mice display a striking dentin 
phenotype, which occurs post-natally. We propose that Dkk1 in pulp and odontoblast 
cells directly or indirectly (though the inhibition of Wnt signaling) controls post-natal 
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mandibular molar development at three levels: (i) gene expression (through molecules 
such as Osx and Nestin) and cell maturation; (ii) dentin ultrastructure; and (iii) dentin 
mineralization. 
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CHAPTER IV 
 
EFFECTS OF OVER-EXPRESSING DKK1 ON OSTEOBLAST AND 
OSTEOCLAST HOMEOSTASIS 
 
Overview  
Dickkopf-1 (Dkk1) is a potent inhibitor of the Wnt/β-catenin signaling pathway. 
Deletion of the Dkk1 gene in mice leads to embryonic lethality, whereas transgenic mice 
over-expressing Dkk1 in mature osteoblasts result in osteopenia and severe cranial vault 
abnormalities. The study of Dkk1-Transgenic (Dkk1-Tg) mice aims to determine the 
effect of over-expressing Dkk1 in regards to calvarial osteogenesis by overexpressing the 
gene in mature osteoblasts following activation of the 2.3-kb Col1a1 promoter. Dkk1-Tg 
mice possess a markedly reduced calvarial bone density and multiple regions lacking 
any bone mineralization within the cranial vault, indicative of an osteogenic deficiency. 
Analyses performed by micro-computed tomography confirmed a >60% reduction of 
bone volume/total volume (bone fraction) within the parietal bone. The sagittal suture 
displays incomplete articulation of the parietal bones due to a combination of decreased 
mineralization and altered bone marker expression. Calvarial osteocytes are irregularly 
shaped, more rounded, non-spindle shaped, and abnormally small. Interestingly, there 
was a considerable increase in osteoclast cell number and activity as well as an unusual 
positioning of these cells on the endocranial surface of the calvarium. The expression of 
osteoblast/osteocytes cell markers Dkk1, Sost, Dmp1, Bsp, Opn, Alp and Osx were 
increased, while Runx2 expression was unchanged. Markers of osteoclast activity: Trap, 
CatK, Mmp-9 were significantly increased. Osteoclast differentiation and maturation 
markers: RANKL and M-CSF were increased, while expression of OPG was unchanged. 
Together, these data indicate that Dkk1 plays a role in calvarial osteogenesis by directly 
affecting osteoblast activity and indirectly increasing osteoclast number and activity. 
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Introduction 
Dkk1, a soluble secreted Wnt antagonist, has been documented to play a key role 
in bone development and remodeling through its binding to the Lrp5/6 Kremen complex 
(13, 28, 42, 89, 90). The conventional deletion of the Dkk1 gene in mice negatively 
affects their development resulting in embryonic lethality due to a lack of anterior head 
structures (77). Interestingly, with the ability to balance Wnt-signaling levels throughout 
development, the anterior head truncation could be rescued with the use of a doubleridge 
mouse, which reduced Lrp6 expression levels (91). Other work has shown that over-
expression of Dkk1 (driven by the 2.3-kb Col1a1 promoter) causes osteopenic effects in 
the skeleton (13).  
Pivotal cells in bone formation, regulation and turnover include the osteoblasts 
and the osteoclasts. The osteoblasts are the cells responsible for bone formation whereas 
the osteoclasts are terminally differentiated, multinucleated cells responsible for bone 
resorption. These two cell types work in collaboration with one another to maintain bone 
homeostasis (29). To promote osteoclast differentiation osteoblasts secrete Receptor 
Activator of Nuclear Factor Kappa-B Ligand (RANKL), which is then free to bind to 
Rank, a protein expressed by osteoclasts (30). Osteoblasts also secrete macrophage-
colony stimulating factor (M-CSF), which has shown an effect in osteoclast 
differentiation, but is not needed for the resorbing activity of osteoclasts (31). The 
counter-response to RANKL:RANK binding and osteoclast differentiation into a 
multinucleated osteoclast is modulated by the osteoblasts' expression of Osteoprotegerin 
(OPG), a decoy receptor. OPG binds to RANKL, preventing RANKL from binding 
RANK, thereby preventing osteoclastogenesis (32). Determination of the extent of 
normal bone resorption depends heavily on the ratio of RANKL:OPG. Once activated, 
osteoclasts stimulate resorption and degradation of the boney matrix, by expressing 
enzymes, such as Tartrate-Resistant Acid Phosphatase (TRAP), a glycosylated 
monomeric metallo-enzyme, Cathepsin K, a lysosomal cysteine protease, and Matrix 
Metallo-Proteinase-9 (Mmp-9), an extracellular matrix proteinase. These proteins are 
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secreted into the osteoclasts’ lacunae, the space between the cell and their attachment 
site to the extracellular mineralized matrix, and degrade the matrix (33). 
Bone formation is regulated by many different bone markers expressed through 
different pathways. Osterix (Osx) is a key player in bone formation whose expression 
has been previously documented to be under the control of Runx2. Runx2 knockout 
(KO) mice lack bone formation completely and Osx KO mice are unable to form bone 
due to an arrest of osteoblast differentiation. Interestingly, an overexpression of both 
Runx2 and Osx under the expression of the 2.3-kb Col1a1 promoter leads to an 
osteopenic phenotype in the long bones similar to that which is seen in 2.3-kb Col1a1 
Dkk1-Tg mice. Osx is known to be pivotal in osteoblastic differentiation during the early 
stage of osteoblast differentiation, but during the later stages it is evident that Osx has an 
inhibitory function leading to an accumulation of immature osteoblasts. Osx is regulated 
by Runx2 as well as by the Bone Morphogenetic Protein (BMP) pathway. A potential 
interaction between the Wnt signaling pathway and the BMP pathway has been 
identified in our study that could lead to evidence of Osx expression regulation 
independent of Runx2. 
Osteoclastic bone resorption has been indicated in patients with osteolytic bone 
diseases such as multiple myeloma (34). Speculations as to the driving force behind 
multiple myeloma lytic bone disease include both osteoblastic inhibition (such as with 
an over-expression of Dkk1) (35), and osteoclastic stimulation leading to an uncoupling 
of bone homeostasis. Dkk1 negatively regulates Wnt/β-catenin signaling and in turn 
functions as a critical regulator of bone physiology. Specific aspects of the Wnt/β-
catenin signaling pathway have been studied within osteoblasts but a relatively scant 
amount of research has focused on the crosstalk of Wnt/β-catenin signaling and BMP 
signaling in osteoblasts. Studying the effects of Dkk1 on bone in the very serious and 
devastating lytic bone disease in humans (36, 37). Research has shown that there is a 
definitive link between patients with multiple myeloma and an over-secretion of Dkk1 
from the patients’ plasma cells (35, 38, 39). Elevated levels of Dkk1, present in the 
plasma and peripheral blood, were then subsequently correlated with the formation of 
  42 
lytic bone lesions and the “punched out” bone lesions in the calvarium. Bone marrow 
biopsy specimens stained for Dkk1 exhibited very elevated levels, and also presented 
with an increased Dkk1 antibody staining within plasma cells adjacent to the bone (36, 
40). Furthermore, Dkk1’s involvement in multiple myeloma links the over-expression of 
the Dkk1 protein to a disruption in the balance between osteoblastic and osteoclastic 
activity. Patients with multiple myeloma have presented with markedly increased 
osteoclastic activity in contrast to a significantly diminished osteoblastic activity. The 
osteolytic lesions formed in a significant amount of patients with multiple myeloma 
seem to occur due to osteoclastic hyper-activation combined with osteoblastic inhibition.  
The Dkk1-Tg mouse model used in this study proposes a method to more closely 
study the lytic bone lesions formed in multiple myeloma by bypassing the plasma cell 
discrepancy. Secreted Dkk1 from plasma cells adjacent to bone 
(osteoblastic/osteoclastic) cells is able to directly affect these cells whereas within the 
Dkk1-Tg mouse model, mature stage osteoblasts are secreting elevated levels of the 
Dkk1 protein, which is then able to act through autocrine/paracrine signaling on the 
osteoblasts. Other data presented with inconclusive evidence regarding the effects of 
Dkk1 on osteoclasts (92).  
Although Dkk1 appears to have a significant role in the balance of osteoblastic 
and osteoclastic activities, the precise role of osteoclastogenesis in multiple myeloma 
lytic bone disease still remains unclear regarding Dkk1 and the bone microenvironment. 
The role of Wnt/β-catenin signaling and the effect of Dkk1 on the Wnt/β-catenin 
signaling pathway regulating osteoclastic activity are still presently unknown. In this 
study we aimed to determine the effects of over-expressing Dkk1 in mature osteoblasts 
to further study the effect on osteoclastic activity and bone homeostasis. The Dkk1-Tg 
mouse model allows for concentration on determining the relationship between Dkk1 
expression and osteoblastic/osteoclastic activity as it is still unclear how the over-
expression of Dkk1 in osteoblasts affects osteoclastic activity. Here we present a 
hypothesis by which Dkk1 negatively regulates the Wnt signaling pathway, which then 
releases inhibitory activity on the BMP pathway stimulating Osx expression. Osx 
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expression at this later time point in differentiation then acts as a blocker of osteoblast 
differentiation from immature osteoblasts into mature osteoblasts. Osx expression also 
regulates RANKL and M-CSF expression increasing osteoclastogenesis. 
 
 
Experimental Procedures 
Animals 
This study was conducted in accordance with federal animal care guidelines. All 
mice were maintained under guidelines established by Baylor College of Dentistry 
Institution of Animal Care and Use Committee (IACUC). For these studies, WT mice, 
2.3-kb Col1a1 Dkk1-Tg mice (Amgen), and TOPGAL mice were used. Generation of the 
Dkk1-Tg mice has been described previously (13). Animals were housed under normal 
conditions with standard light cycles, and fed a standard rodent chow and tap water. Age 
groups included: P0, 2-wks, 4-wks, 12-wks, and 24-wks. Animals were genotyped as 
previously described. 
 
Radiography and Microcomputed Tomography (µCT) 
Radiographs were taken using Faxitron radiographic inspection unit (Model 
8050, Field Emission Corporation, Inc), with digital capture image capability. µCT 
Analyses were performed using a Scanco Medical µCT 35 (Scanco Medical AG, 
Switzerland) of Dkk1-Tg and WT whole head samples from each age group using high 
resolution µCT scanning. Overall 3-D assessment will depict the shape/morphology of 
the calvarial bones, as well as allow for visualization and quantification of the quality of 
the calvarial bones by morphometric analyses. A comparable region between the WT 
and Dkk1-Tg parietal bones will be contoured (selected out) separately from the rest of 
the surrounding calvarial (cranial vault) bones to analyze in detail the bone quality and 
bone thickness. Measurements are made by running bone volume/density and bone 
trabecular morphometry scripts (µ-CT program) on various contoured regions. 
Measurements include: apparent density, cortical thickness, and average trabecular 
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thickness, number and separation.  
FITC staining 
Fluorescein isothiocyanate, a small molecular dye, will fill in the calvarial 
cells/fibers such as osteoblasts, osteocytes and osteoclasts, without staining the mineral 
matrix. Thus, the dye provides a visual representation of the organization of the bone. 
Immediately after harvest and dissection a coronally cut section of the skull that included 
the parietal bones was placed in EM fixative (0.5%gluteraldehyde, 2% 
paraformaldehyde in 0.05 M cacodylate-sodium buffer, pH 7.4) at room temperature 
(RT) and then processed and cut with a diamond blade saw (Buehler, Lake Bluff, IL) to 
obtain coronal section with 300-400 µm cross-sectional thickness. The sections were 
placed back into EM fixative for 24 hours at RT. The sections were then sanded down 
and polished to a final thickness of 30-50 µm for confocal imaging. 
Analysis of bone formation rate by double-labeling 
To examine the bone formation rate, we performed double-fluorescence labeling 
as described previously (79). Briefly, a calcein label (5 mg/Kg i.p.; Sigma-Aldrich, St. 
Louis, MO, USA) was administered to 20-day-old mice, followed by administration of 
calcein 7 days later. Mice were sacrificed 2 days after the second injection (1 mo old). 
The non-decalcified calvaria were embedded in resin (methylmethacrylate, MMA), 
sectioned, and photographed under epifluorescent illumination with a Nikon 800 
microscope (Nikon, Melville, NY, USA).  
Scanning Electron Microscopy (SEM) and resin-casted SEM 
Selected calvarial bone tissues will be fixed in 70% ethanol and embedded in 
methyl-methacrylate (MMA, Buehler, Lake Bluff, IL). For backscattered SEM, the 
surface of the MMA embedded bone will be polished, and coated with gold, and 
examined by FEI/Philips XL30 Field emission environmental SEM (Hillsboro, OR, 
USA). For resin casted SEM, the above samples will be polished again to take away the 
previous coated materials followed by acid treatment for 5-10 seconds. Combinations of 
both assays will reveal morphological changes of the osteocyte, overall bone structure, 
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bone mineral and bone loss in WT mice and Dkk1-Tg mice. SEM will be performed 
within specified regions along the parietal bone. 
 
Histology and immunohistochemical staining 
Calvarial bones were cut coronally and sagitally (for different imaging), fixed in 
4% paraformaldehyde (PFA), decalcified with 10% EDTA, and embedded in paraffin by 
standard histological procedures as previously described (93). Serial sections were cut 
(4-5 µm thick) and mounted on glass slides. Sections were then used for Hematoxylin 
and Eosin (H&E) staining, immunohistochemistry, TRAP staining and LacZ staining. 
DKK1 (Abcam, Cambridge, UK) immunostaining was performed on histological 
sections of the WT and Dkk1-Tg calvaria based on methods described previously (94). 
Polyclonal antibodies Sost, Dmp1, and Bsp were used for detection of osteocytes, 
osteoblasts and bone matrix. TRAP (Tartrate resistant acid phosphatase) staining was 
performed to detect TRAP+ osteoclasts that are actively resorbing bone. Whole mount 
B-galactoctosidase staining was performed to detect Wnt signaling on paraffin sections. 
The staining methods were performed according to the manufacturer’s instructions. 
 
Cell culture, RNA isolation and quantitative PCR (qPCR) analysis 
To examine the effects of over-expressed Dkk1 on the calvaria, primary calvarial 
osteoblasts were isolated from 3 sets of four-day-old WT and 3 Dkk1-Tg mice parietal 
bones. The osteoblasts were seeded at a concentration of 1 x 104 into 3 wells a 48 well 
plate per animals (total of 18 wells for 6 animals). Cells were cultured in alpha 
Minimum Essential Medium (α-MEM) supplemented with 10% fetal bovine serum 
(FBS), 100 units/ml penicillin and 100 µg/ml streptomycin. Media was changed every 2 
days. After 4 days, the isolated primary osteoblast cells from Dkk1-Tg and WT mice 
were harvested for RNA isolation and quantitation analysis of gene expression by real 
time RT-PCR. RNA was isolated using RNeasy Mini Kit (Qiagen, 74106) according to 
the manufacturer’s protocol. After isolation, 1 µg of total RNA treated with DNase and 
was reverse-transcribed in first strand cDNA using QuantiTect Rev. Transcription Kit 
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(Qiagen, 205311). Using 10 µl SYBR GREEN qPCR, reactions were performed in a 96 
well optical reaction plate formatted in a CFX96 Bio-Rad real-time PCR (qPCR) 
machine with a standard reaction protocol. The transcript of GAPDH mRNA was 
employed as an internal control for RNA quality. For each gene, three independent RT-
PCR reactions from the same reverse transcription sample were also performed for 
accuracy. The genes analyzed were osteoblast markers: Dkk1, Dmp1, Bsp; osteocyte 
markers: Sost, and osteoclast markers: Trap, Cathepsin-K, Mmp-9, Rankl, Opg, and m-
CSF. Gapdh was used as the internal control.  
 
Statistical analyses 
The data analysis was performed with a student t-test. Each experiment was 
performed in triplicate experimentally and biologically. The quantified results are 
represented as the mean ± standard error of the mean (SE). We set p < .05 as the 
statistical significance level.  
 
 
Results 
Dkk1-Tg calvaria present with osteolytic-like lesions  
Dkk1-Tg mice overexpress Dkk1 under the 2.3-kb Col1a1 promoter (Fig. 3-1A) 
and show expression levels around 30-fold higher than wildtype (WT) control mice (Fig. 
3-1B). Dkk1-Tg mice present with a relatively shortened stature (Fig. 3-2A) as well as a 
significant decrease in body weight (Fig. 3-2B). These mice present with osteolytic-like 
lesions within the calvarial bones, with most striking effects seen within the parietal 
bones, as determined with radiographic imaging (Fig. 3-2C). A diminished bone 
formation within the calvarial bones was also observed between littermate control and 
Dkk1-Tg calvaria at multiple different developmental as well as adult time points: P0, 4-
week, and 12-week-old mice, as determined by analyses using micro-computed 
tomography (µ-CT) (Fig. 3-3A). The parietal bone phenotype was our focus for this 
study since it was the major constituent of the cranial vault consistently negatively 
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affected in Dkk1-Tg mice throughout development and into adulthood.  The overall 
quality of the parietal bone was determined by selecting (contouring) out a single 
parietal bone for analysis using µ-CT software and assessing multiple parameters. The 
apparent density of the transgenic parietal bone was significantly lower than the WT 
parietal bone with greater than a 60% decrease in bone volume/total volume (bone 
fraction volume). There was also a significant decrease in apparent density and mineral 
density (Fig. 3-3B) showing a decrease in bone mineral density.  
 
Defects in osteocyte morphology and bone quality 
To further investigate the quality of the Dkk1-Tg calvarial bone and osteocyte 
cell morphology, FITC (Fluorescein isothiocyanate) labeling of the WT and Dkk1-Tg 
parietal bone was performed (Fig. 3-4A). FITC labeling confirmed the presence of 
osteolytic lesions interspersed with small bone-islands in the transgenic skull by 
detecting and staining cells but not staining mineralized material such as bone. 
Qualitatively, the stain displayed the osteocytes as having a substantial decrease in the 
number of dendritic processes radiating from the osteocytes as well as the presence of 
rounded osteoblast-like cells instead of spindle-shaped osteocytes. Scanning Electron 
Microscopy (SEM) showed a considerable qualitative decrease in parietal bone 
mineralization (Fig. 3-4B, C). The transgenic osteocytes/potential immature osteoblasts 
appear clumped together and abnormal in shape, with multiple cells sharing the same 
lacunae. The parietal bones, which abut on either side of the intervening sagittal suture, 
do not fuse in control mice normally, but rather they closely abut one another, whereas 
the Dkk1-Tg parietal bones are a significant distance from the anticipated abutment 
region (Fig. 3-4B). The cells reside in significantly under-mineralized areas of bone 
interspersed within the fibrous lesions. The matrix was poorly organized, lacking well-
formed lacunae in which the cells reside. Also, the cell shape was altered from its normal 
osteocyte morphology, which can be visualized in the SEM acid-etched WT and Dkk1-
Tg parietal bone imaging. The Dkk1-Tg cells are smaller and appear deflated (Fig. 3-
4D). 
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The parietal sutures of the transgenic mice were also affected most likely due to a 
lack of bone mineralization but appear to align correctly from a developmental 
standpoint.  In the WT murine cranial vault, the posterior frontal suture is the only suture 
that fuses, while the other cranial bone fronts closely articulate and align with one 
another.  In the Dkk1-Tg mice, the posterior frontal suture fuses as normal, while the 
parietal bone abutment has a consistent gap where the fusion would normally have taken 
place (Fig. 3-5).  It is assumed that the sagittal suture is wider due to a mineralization 
defect rather than a defect in suture development.   
 
Significant alteration of Dkk1-Tg bone formation rate  
The bone formation rate measured through the utilization of double calcein 
labeling methodology showed a decreased in bone formation on the endo-cranial surface 
and an increase in bone formation on the ecto-cranial surface (Fig. 3-6). The diminished 
bone formation on the endo-cranial surface is theorized due to the increase in the 
osteoclastic cell number and activity present on this bone surface as seen via the 
significant increase in tartrate resistant acid phosphatase positive (TRAP+) staining (Fig 
3-7A). The increase in bone formation on the ecto-cranial surface is presumed to be 
present in a compensatory response to the increase in bone resorption on the endo-
cranial surface. 
 
Increase in osteoclast differentiation combined with an increase in resorptive activity 
In 2-week and 4-week old Dkk1-Tg mice, there was a significant increase in 
TRAP+ staining on the endo-cranial surface of the parietal bones, suggesting sustained 
high levels of resorptive activity occurring in this area (Fig. 3-7A).  Dkk1-Tg mice also 
exhibit a 9.5-fold increase in Trap mRNA expression, a 9.5-fold increase in Cathepsin-K 
mRNA expression and a 5.5-fold Mmp-9 (matrix metalloproteinase 9) mRNA expression 
(Fig. 3-7B). Collectively, these data suggest that the Dkk1-Tg parietal bones possess an 
increase in osteoclastic activity of the mineralized regions. The osteoclast differentiation 
factors expression levels were then measured by reverse transcription real-time PCR (RT 
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qPCR) in the WT control and Dkk1-Tg mice parietal bones to determine if expression 
changes were evident. In the transgenic mice, we observed ~2.5-fold increase in RANKL, 
and a 1.8-fold increase in M-CSF but no concomitant increase in OPG mRNA 
expression (Fig. 3-7C). 
 
Decrease in β-catenin nuclear translocation and activation of downstream effector 
genes in osteoblasts and osteocytes 
To determine the effect of overexpression of Dkk1 on canonical Wnt signaling in 
calvarial parietal bone, Dkk1-Tg mice were crossed with Wnt reporter (TOPGAL) mice 
that express the lacZ gene encoding E. coli β-galactosidase under the control of three 
Lef1/Tcf consensus binding sites linked to a minimal promoter (85). Expression of the 
transgene-specific, E. coli β-galactosidase staining was greatly increased in parietal bone 
from 2-week-old Dkk1-Tg mice compared to those in WT littermates shown as whole 
mount B-gal staining (Fig. 3-8A) and parietal bone sectioning (Fig. 3-8B). LacZ 
expression was seen prominently in osteoclasts (previously documented to be increased 
due to the increased activity (95)) within the Dkk1-Tg parietal bone and was severely 
reduced/absent in the osteocytes. In the WT littermates, lacZ expression was seen in 
osteocytes and osteoblasts. 
 
Significant alterations in bone marker gene expression as well as a maintenance of 
osteoblasts in an immature State 
Histologically, hematoxylin and eosin (H&E) stained sections of transgenic 
calvaria as compared to wildtype calvaria, displayed fibrous-like tissue regions lacking 
mineralization, which were interspersed between under-mineralized islands of trabecular 
bone (Fig. 3-9A). Interestingly, the calvarial osteoblasts lining the regions of bone 
showed a significant increase in Osx protein expression (Fig. 3-9B). Osx expression 
increase was confirmed via RT qPCR, whereas the expression of Runx2 was unchanged 
(Fig 3-10). Along with this data, protein expression of Bone sialoprotein (Bsp) and 
Osteopontin (Opn) were increased providing evidence of immature osteoblast markers 
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and immature bone formation (Fig. 3-11). On the contrary, there was a significant 
decrease in Osteocalcin (Ocn) expression, a well-known mature osteoblast marker. This 
data was further confirmed with RT qPCR, with a 3.5-fold increase in Bsp expression, a 
2.9-fold increase in Opn expression, a 3.2-fold increase in Alp expression and a 5-fold 
decrease in Ocn expression (Fig. 3-12). 
Interestingly, even though the Dkk1-Tg parietal bone presented with disrupted 
mineralization and a decreased bone density, the osteocytes displayed an increase in 
Sclerostin (Sost) expression (Fig. 3-13A) as well as Dentin Matrix Protein (Dmp1) (Fig. 
3-13B) as shown by immunohistochemical staining (IHC). This data was further 
confirmed with real-time PCR (qPCR) from purified mRNA extracted from isolated and 
homogenized WT and Dkk1-Tg paired parietal bones showing ~3-fold increase in Sost 
mRNA expression, ~4.5-fold increase in Dmp1 expression (Fig. 3-14). 
 
 
Discussion 
In search for potential roles of Dkk1 in craniofacial bone development, we 
studied the 2.3-kb Col1a1 Dkk1-Tg mice, which exhibits striking osseous defects in the 
calvaria.  Dkk1-Tg mice over-express Dkk1 in immature and mature osteoblasts due to 
the nature of the 2.3-kb Col1a1 promoter and its expression-dependent manner in 
osteoblasts around E14.5 (previously reported using R26R reporter mice) (96). Primary 
parietal bone osteoblasts isolated from Dkk1-Tg mice used in this study had an average 
of a 30-fold increase in Dkk1 mRNA expression (Fig. 3-1).  
The main observation in the calvarial bones was an osteopenia-like phenotype 
with a woven bone appearance. The parietal bones displayed a decreased mineral 
density, compared to WT controls, and regions of the bone were interspersed with 
fibrous-like regions of cells in which there is a complete absence of mineralization. 
Interestingly, the osteoblast cell density was increased as shown using an Osx expression 
marker, but overall bone formation was reduced. Most of the osteoblasts can be 
characterized as immature osteoblasts due to the increase in immature osteoblast marker 
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expressions of Opn and Bsp. Mature osteoblasts are known to express Ocn and this was 
reduced 5-fold in Dkk1-Tg osteoblasts. Furthermore, in Dkk1-Tg mice there was a 
significant increase in Osx protein expression. An increase in Osx could explain the 
increase in immature osteoblast-specific markers such as Bsp, Opn and Alp (97). This 
model could explain a role of Dkk1 expressed in osteoblasts under the 2.3-kb Col1a1 
promoter in immature and mature osteoblasts.  
Due to the similarity in phenotype of the 2.3-kb Col1a1 Osx-Tg mice (44) to the 
2.3-kb Col1a1 Dkk1-Tg mice, our data may connect the gap to a potential link between 
Dkk1 and Osx. A major difference in the two mouse models is that there is no change in 
osteoclastic activity in Osx-Tg bone, but this analysis was performed on the femur bone 
(long bone), which is formed through endochondral ossification. Dkk1-Tg mice cortical 
femur bone was also not noted to show a change in osteoclast number or activity (13). 
This can be assumed to be a mechanistic difference between endochondral and 
intramembranous ossification pathways as we were able to show that the alveolar bone 
(formed through intramembranous ossification) did present with an increase in osteoclast 
cell number and activity (98). Therefore, we hypothesize that an increase in Dkk1 in the 
immature to mature transition osteoblast stage increases Osx activity, which then 
maintains the cells in a proliferative immature undifferentiated state. At the stage that the 
Col1a1 promoter is active, Osx does not have this function, as its major function is in 
early pre-osteoblastic cells.  
Ocn is a very late and specific osteoblast marker and it is usually expressed 
around E18.5. With the significant decrease in Ocn expression in Dkk1-Tg parietal bone, 
this demonstrates the characteristic decrease in the number of cells in a mature 
osteoblastic state. Osteoblast differentiation is inhibited and immature osteoblasts are 
accumulated (99). These data suggest that proper doses of certain proteins are required 
to promote osteoblast differentiation and bone formation. The increase in Sost and Dmp1 
which are known mature osteocyte markers could be increased due to a compensatory 
response of those osteoblasts that were already matured prior to the activation of the 
transgenic promoter.  
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Since bone development and homeostasis requires a balance between formation 
and resorption we hypothesize that there is an increase osteoclast function due to the 
prior knowledge that immature osteoblasts act in a potentially pro-osteoclastogenic 
manner (100). Additionally, it has been documented that osteoblasts serve a dual role, 
either in support of osteoclastogenesis or in support of bone formation, and these two 
roles may be performed by the same lineage of cells at different stages of their 
maturation. 
The osteoclasts showed an overall increase in TRAP production, as well as 
increased Mmp-9 and Cathepsin K expression. These data confirm the increase in 
osteoblast maturation and activity. The imbalance of RANKL:OPG ratio likely results in 
increased osteoclast maturation and the increased resorptive activity observed. The 
increased RANKL secretion may also repress any feedback inhibition that may occur in 
bone homeostasis not allowing for a let up in bone resorption. Multiple myeloma cells 
were hypothesized to increase the secretion of RANKL from osteoblasts and Dkk1-Tg 
mice also show an increase a 2.5-fold increase in RANKL secretion. This increase in 
RANKL secretion allows for an increase in osteoclast maturation and activation. Also, it 
is noted that the increase in TOPGAL staining for β-catenin signaling is increased in 
osteoclasts. As Dkk1 is a negative inhibitor of the Wnt signaling pathway, the location 
of the wnt signaling shows that Dkk1 is blocking the signaling in osteoblasts (which are 
dispersed around the edges of the woven bone) but Wnt activity is still very strong in the 
osteoclasts. Rather, the increase in RANKL leads to a subsequent increase in 
osteoclastogenesis. Therefore, in the transgenic animals, over-expression of Dkk1 is able 
to enhance the levels of RANKL expression, which has also been confirmed in other 
studies (32). This hypothesis is supported by data showing that Dkk1 significantly 
increased RANKL mRNA expression in mouse primary parietal bone osteoblast cells in 
contrast to comparative WT control cells (Fig. 6B). There is an uncoupling of the bone 
remodeling activities in favor of bone resorption with an increase in osteoclast-mediated 
destruction. It must be mentioned though, that there is the potential for Dkk1, which is 
expressed under the 2.3-Col1a1 promoter and secreted by osteoblasts into the 
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surrounding environment to target pre-osteoblastic cells lining the ossifying bone fronts 
in a paracrine manner. 
Our mouse model partially recapitulates the multiple myeloma tumor micro-environment 
with regards to secreted Dkk1 as a key regulator and its direct effects on osteoblast 
proliferation and maturation and its indirect effect on osteoclast maturation and 
activation. This mouse model is a potentially excellent viable mouse model to study the 
effects of Dkk1 specifically targeting the lytic bone lesions, which occur later in adult 
life. 
We hypothesize that due to previous studies suggesting a crosslink between Wnt 
signaling and BMP signaling that Dkk1 acts as a Wnt signaling antagonist and this then 
removes the block that Wnt would normally have on BMP signaling and subsequent 
suppression of Osx at this time point during osteoblast differentiation (101). The 
increase in Osx expression maintains the osteoblasts in an immature state. Osx has also 
been shown to regulate Rankl and M-csf expression as well as Sost expression (102-104) 
(Fig 3-15). 
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CHAPTER V 
 
CONCLUSION 
 
Dkk1 has an important role in osteogenesis and odontogenesis, two very 
important developmental processes. When Dkk1 is over-expressed in immature and 
mature odontoblasts and osteoblasts disruptive changes in odontogenesis, 
osteoblastogenesis, and osteoclastogenesis. 
 
Role of Dkk1 in Odontogenesis 
Upon studying Dkk1-Tg mouse tooth development, our main findings were: (1) 
The 2.3-kb Col1a1 promoter is known to be active, and therefore regulating over-
expression of Dkk1 in pre-odontoblasts and odontoblasts prior to the late bell stage 
(E16.5). At this stage, the inner enamel epithelium sends signals to the cells adjacent to 
them lining the dental papilla to become odonotoblasts. Therefore the cells are mostly 
within the pre-odontoblastic to odontoblastic transitional stage during the activation of 
the transgene; (2) Dkk1-Tg mandibular molars display a severe post-natal phenotype, 
including short roots, an enlarged pulp/root canal region, thin dentin, a considerable 
reduction in the dentin formation rate, a small malformed second molar, and an absent 
third mandibular molar; and (3) changes of Osx and Nestin expression in the 
odontoblasts, an increased number of immature odontoblasts, few mature odontoblasts, 
and a sharply reduced dentinal tubule number. The increase in expression of Osx within 
the cells lining the dentin within the root canal could explain the role of Osx expression 
at this time-point in keeping the cells in a pre-odontoblastic immature stage and 
increasing the proliferation of these cells rather than allowing the cells to differentiate 
into mature polarized odontoblasts. The lack of mature polarized odontoblasts effects the 
maturation of the dentinal tubules, the thickness of the dentin (which is shown to be 
reduced in Dkk1-Tg molar root dentin) and the reduction in the dentin formation rate.  
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The actual role of Wnt/β-catenin or Dkk1 in post-natal tooth (especially root) 
formation is not clear, since previous work mainly focused on tooth germ and crown 
formation during embryonic development. In this work, we directly target Dkk1 in 
odontoblastic cells during the post-natal developmental stage. Analysis of our data 
clearly showed a striking dentin phenotype, suggesting that Wnt/β-catenin signaling 
continuously plays a key role during post-natal dentin formation. 
Thus, we propose that Dkk1 controls post-natal mandibular molar dentin 
formation either directly or indirectly via inhibition of Wnt signaling in the following 
levels: (i) post-natal dentin formation, (ii) formation and/or maintenance of the dentin 
tubular system, (iii) mineralization of the dentin, and (iv) regulation of molecules such as 
Osx and Nestin.  
It was noted that the alveolar bone expresses the Dkk1-transgene in a similar 
pattern as does the calvarial bone and therefore as well as it harboring an increased 
number of osteoclasts which plague the alveolar bone surface. Interestingly, there was an 
increase in the number of osteoclasts that were present along the external surface of the 
root lining the dentinal surface adjacent to the PDL. There also appears to be a 
disruption in the formation of the layer of acellular cementum. Acellular cementogenesis 
is necessary at the root surface to allow for the anchorage of PDL fibers providing a 
strong attachment of the tooth to the alveolar bone (105).  Future studies are needed to 
concentrate the effect of Dkk1-mediated disruption of acellular cementum. 
Interestingly, the 2.3-kb Col1a1 Dkk1-transgene is active in pulp and odontoblast 
cells, while there is no sign of the 3rd mandibular molar in all Dkk1-Tg mice examined 
by radiograph, with 6 samples at the age of 2 wks and 6 samples at the age of 4 wks 
(Fig. 2-2). With an H&E staining assay, we noticed an empty cavity within the Dkk1-Tg 
mandibular alveolar bone where the 3rd molar should be (data not shown), suggesting 
that the tooth germ was formed but its growth was arrested and then it was subsequently 
resorbed. Thus, we speculate that the high level of Dkk1 released from pulp cells either 
directly or indirectly (through the inhibition of Wnt/β-catenin signaling) blocks further 
development of the 3rd molar. At this stage, we do not know whether this inhibitory role 
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is Wnt/β-catenin-dependent or –independent, or both. Future generation of an 
odontoblast-specific Dkk1 knockout animal model would yield a clearer picture of the 
roles of Dkk1 in post-natal tooth development. In addition, we plan to cross the 2.3-kb 
Col1a1 Dkk1-Tg mice to the Top-Gal mouse line (85), to determine whether lacZ 
expression, which reflects Wnt/β-catenin signaling, is altered in the Dkk1-Tg tooth. 
The severe dentinal resorption on the Dkk1-Tg root surface shows a severe defect 
that could be due to the increase in osteoclast cell number, maturation and activation. 
Another alternative explanation could be due to the fact that the defect in the acellular 
cementum promotes dentinal erosion and ablation. It is known that Wnt signaling up-
regulates Opg in the mature osteoblast, which blocks Rankl-induced osteoclastogenesis 
(87). Over-expression of Dkk1 increases osteoclast cell number and their subsequent 
activation via an inhibition of Wnt signaling and an increase in RANKL secretion. 
In summary, 2.3-kb Col1a1 Dkk1-transgenic mice display a striking dentin 
phenotype, which occurs post-natally. We propose that Dkk1 in pulp and odontoblast 
cells directly or indirectly (though the inhibition of Wnt signaling) controls post-natal 
mandibular molar development at three levels: (i) gene expression (through molecules 
such as Osx independently from Runx2 (106)) and cell maturation; (ii) dentin 
ultrastructure; and (iii) dentin mineralization. 
 
Role of Dkk1 in Cranial Vault Osteogenesis 
Initial studies of 2.3-kb Col1a1 Dkk1-Tg mice dentinal phenotype and alveolar 
bone phenotype lead to further investigation of other bone defects such as the striking 
osseous defects within the calvarial bones.  Dkk1-Tg mice over-express Dkk1 in 
immature and mature osteoblasts (as well as within the pre-odontoblasts/odonotoblasts) 
due to the nature of the 2.3-kb Col1a1 promoter.  
The Dkk1-Tg presentation of the osteopenic-like phenotype within the calvaria 
with the presence of a woven bone appearance and the decreased mineral density, 
confirmed the presence of a mineralization defect. The increase in density of immature 
osteoblasts (displayed through use of an Osx expression marker) as well as a significant 
  57 
disruption in various bone markers confirmed an osteoblastic deficiency. Mature 
osteoblasts markers such as Ocn was significantly reduced in Dkk1-Tg calvarial bone, in 
contrast to an increase in immature bone markers such as Bsp, Opn and Alp (97). This 
model could explain a role of Dkk1 expressed in osteoblasts under the 2.3-kb Col1a1 
promoter in immature and mature osteoblasts.  
Due to the similarity in phenotype of the 2.3-kb Col1a1 Osx-Tg mice (44) to the 
2.3-kb Col1a1 Dkk1-Tg mice, our data may connect the gap to a potential link between 
Dkk1 and Osx. A major difference in the two mouse models is that there is no change in 
osteoclastic activity in Osx-Tg bone, but this analysis was performed on the femur bone 
(long bone), which is formed through endochondral ossification. Dkk1-Tg mice cortical 
femur bone was also not noted to show a change in osteoclast number or activity (13). 
This can be assumed to be a mechanistic difference between endochondral and 
intramembranous ossification pathways as we were able to show that the alveolar bone 
(formed through intramembranous ossification) did present with an increase in osteoclast 
cell number and activity (98). Therefore, we hypothesize that an increase in Dkk1 in the 
immature to mature transition osteoblast stage increases Osx activity, which then 
maintains the cells in a proliferative immature undifferentiated state. At the stage that the 
Col1a1 promoter is active, Osx does not have this function, as its major function is in 
early pre-osteoblastic cells.  
Ocn is a very late and specific osteoblast marker and it is usually expressed 
around E18.5. With the significant decrease in Ocn expression in Dkk1-Tg parietal bone, 
this demonstrates the characteristic decrease in the number of cells in a mature 
osteoblastic state. Osteoblast differentiation is inhibited and immature osteoblasts are 
accumulated (99). These data suggest that proper doses of certain proteins are required 
to promote osteoblast differentiation and bone formation. The increase in Sost and Dmp1 
which are known mature osteocyte markers could be increased due to a compensatory 
response of those osteoblasts that were already matured prior to the activation of the 
transgenic promoter.  
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Since bone development and homeostasis requires a balance between formation 
and resorption we hypothesize that there is an increase osteoclast function due to the 
prior knowledge that immature osteoblasts act in a potentially pro-osteoclastogenic 
manner (100). Additionally, it has been documented that osteoblasts serve a dual role, 
either in support of osteoclastogenesis or in support of bone formation, and these two 
roles may be performed by the same lineage of cells at different stages of their 
maturation. 
The osteoclasts showed an overall increase in TRAP production, as well as 
increased Mmp-9 and Cathepsin K expression. These data confirm the increase in 
osteoblast maturation and activity. The imbalance of RANKL:Opg ratio likely results in 
increased osteoclast maturation and the increased resorptive activity observed. The 
increased RANKL secretion may also repress any feedback inhibition that may occur in 
bone homeostasis not allowing for a let up in bone resorption. Multiple myeloma cells 
were hypothesized to increase the secretion of RANKL from osteoblasts and Dkk1-Tg 
mice also show an increase a 2.5-fold increase in RANKL secretion. This increase in 
RANKL secretion allows for an increase in osteoclast maturation and activation. Also, it 
is noted that the increase in TOPGAL staining for β-catenin signaling is increased in 
osteoclasts. As Dkk1 is a negative inhibitor of the Wnt signaling pathway, the location 
of the wnt signaling shows that Dkk1 is blocking the signaling in osteoblasts (which are 
dispersed around the edges of the woven bone) but Wnt activity is still very strong in the 
osteoclasts. Rather, the increase in RANKL leads to a subsequent increase in 
osteoclastogenesis. Therefore, in the transgenic animals, over-expression of Dkk1 is able 
to enhance the levels of RANKL expression, which has also been confirmed in other 
studies (32). This hypothesis is supported by data showing that Dkk1 significantly 
increased Rankl mRNA expression in mouse primary parietal bone osteoblast cells in 
contrast to comparative WT control cells (Fig. 6B). There is an uncoupling of the bone 
remodeling activities in favor of bone resorption with an increase in osteoclast-mediated 
destruction. 
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Our mouse model partially recapitulates the multiple myeloma tumor micro-
environment with regards to secreted Dkk1 as a key regulator and its direct effects on 
osteoblast proliferation and maturation and its indirect effect on osteoclast maturation 
and activation. This mouse model is a potentially excellent viable mouse model to study 
the effects of Dkk1 specifically targeting the lytic bone lesions, which occur later in 
adult life. 
We hypothesize that due to previous studies suggesting a crosslink between Wnt 
signaling and BMP signaling that Dkk1 acts as a Wnt signaling antagonist and this then 
removes the block that Wnt would normally have on BMP signaling and subsequent 
suppression of Osx at this time point during osteoblast differentiation (101). The 
increase in Osx expression maintains the osteoblasts in an immature state. Osx has also 
been shown to regulate Rankl and M-csf expression as well as Sost expression (102-104) 
(Fig 3-15). An increase in Dkk1 in the transition of immature to mature osteoblasts 
increases Osx expression within these cells. Osx then has the capability to maintain the 
cell in a proliferative immature state that is incapable of differentiating into a mature 
osteoblast. During the developmental stage that the 2.3-kb Col1a1 promoter is active, 
Osx is not expressed highly within the late stage pre-osteoblasts/early mature 
osteoblasts, as its major function is within the early pre-osteoblastic cells. With the 
significant decrease in Ocn expression (an specific late osteoblast marker) in Dkk1-Tg 
parietal bone, this can explain the decrease in the number of cells in a mature 
osteoblastic state. Osteoblast differentiation is inhibited and immature osteoblasts are 
accumulated (99). DKK1 significantly increased RANKL expression in osteoblasts 
inducing an uncoupling of the bone remodeling activities in favor of bone resorption 
with an increase in osteoclast-mediated destruction.  
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Figure 1-1. Generation of a transgenic mouse. The first step is to produce a transgene 
construct which is achieved by two different approaches: The conventional approach is 
to use restriction enzymes to build the complete transgenic unit together, including a 
tissue specific promoter (the size is less than 10 kb in most cases), a gene-of-interest 
(such as GFP reporter), and a polyA tail (to keep the targeted gene stable for translation 
when it is expressed) (A1). The common problem with this method is that the transgene 
expression level is affected by the insertion site plus surrounding genes’ influence. The 
second method is recombineering (recombination-mediated genetic engineering, (A2). 
The advantages to using this technique are: 1) there is no need for positioned restriction 
sites and thus the transgene can be inserted into a ~200 kb (150-350 kb ranges) BAC 
clone; and 2) the expression level of the transgene is identical to that of the endogenous 
gene. B. The transgene generated can be injected into male pronucleus of an oocyte (the 
size is not an issue), which will then be randomly inserted into any site of the 
chromosome. The oocyte with the transgene is then implanted into a psuedo-pregnant 
female foster mouse and the offspring either contain the transgene in their genome 
(transgenic) or do not (wildtype, WT). C. A confocal view of expressions of the Dmp1-
DsRed (signal in pink in osteocytes) generated in A2. Data was generously provided by 
Dr. Stephen E. Harris (UT Health Science Center At San Antonio, TX USA)  
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Figure 1-2. Generation of gene targeted mice using embryonic stem (ES) cells. Step 
1: The designed targeting vector is electroporated into ES cells and targeted ES cells are 
selected for through antibiotic selection. Southern blot and PCR analyses are performed 
to confirm homologous recombination. Step 2: The targeted ES cells are injected into a 
blastocyst and then implanted into a pseudo-pregnant foster female mouse. Step 3: A 
chimeric male of the offspring is backcrossed to a wildtype (WT) female to ultimately 
create a gene-targeted mouse (germline transmission). 
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Figure 1-3. Dmp1-lacZ knock-in mouse line: A useful model for studying gene 
expression and function in craniofacial development. A. A whole-mount X-Gal stain 
of an E15.5 Dmp1-lacZ knock-in embryo (left panel) and two tissue sections stained by 
X-Gal: newborn incisor (upper right), and alveolar bone (lower right), show high lacZ 
expression in the pulp, odontoblast (Od), and osteoblast (Ob) cells (shown in blue). A 
lacZ reporter gene was used to replace exon 6 of the Dmp1 gene. The expression of lacZ 
reflects endogenous Dmp1 expression. Data is adapted from Feng et al. (2003)(107). B. 
H&E stained images revealed thin dentin and enlarged predentin in this knockout (KO) 
1st molar (right), and backscattered SEM images displayed sharp reduction of mineral 
surrounding dentin tubules (white indicating high mineral content) plus structure 
changes in the KO dentin (lower right), suggesting DMP1 is critical for dentin 
mineralization. Data is adapted from Ye et al. (2004)(108). C. Photograph images 
showed severe defects in the KO alveolar bone morphology, indicating an essential role 
of DMP1 in bone remodeling (right images). Data is adapted from Zhang et al. 
(2011)(109). 
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Figure 1-4. Creation of Cre-loxP bone/tooth-specific conditional knockout model. 
Mice expressing Cre-recombinase under a bone/tooth specific promoter are crossed with 
a “floxed” mouse that has lox sites flanking the gene of interest. The resultant offspring 
are Cre-lox mice in which the Cre-recombinase enzyme has looped out (eliminated) the 
gene of interest from the genome. This knockout event occurs only in the tissue in which 
the promoter is active (ex: bone or tooth) and does not affect gene activity in other 
tissues. 
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Figure 1-5. Cre-loxP model utilizing lacZ staining in craniofacial development. The 
10-kb Dmp1-Cre transgenic mouse line is highly active in osteocytes (Ocy) and 
odontoblasts (Od).  A. The 10-kb Dmp1-Cre mouse line (1-month), containing a 10-kb 
promoter plus a 4-kb intron and Cre cDNA, is crossed to the Rosa 26R-lacZ mouse line 
(a ubiquitous gene), in which a stop cassette or “blocker” is inserted into the promoter 
region with two loxP sites to prevent lacZ activation. After crossing, the Cre removes the 
stop cassette and activates the lacZ, whose expression reflects the Cre specificity; B. 
Whole mount skull staining with X-Gal (a substrate of β-Galactosidase) showed strong 
blue staining in the calvaria (upper left) and in the osteocytes (Ocy) (lower left) 
compared to the litter mate control containing ROSA26R only (right images). C. A 
strong blue signal is detected in the odontoblast (Od) layer with a weaker signal in the 
dentinal tubules (left) compared to the littermate controls (right). The data are adapted 
from Lu et al. (JDR. 2007)(110). 
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Figure 1-6. Tamoxifen (Tm), an antagonist of estrogen, induced tissue specific 
conditional knockout (cKO) of Osx (Osterix) in cementum.  A. Osx is a 
transcriptional factor, which is expressed in all mesenchymal derived hard tissues 
(including cellular cementum) and the conventional Osx KO is lethal, whereas 
cementum is formed after birth. To study the role of Osx in cementogenesis, a 3.2 kb 
Col1-Cre ER mouse line is crossed to an Osx-floxed mouse line. In the absence of Tm 
the Cre will not be activated (left panel). In the presence of Tm (Intraperitoneal 
injection, i.p.) the Cre will delete Osx in the nucleus (right panel). C. Backscattered 
SEM images displayed a sharp reduction of cellular cementum sizes in the Osx cKO 
cementum, which is confirmed by H&E stain. WT, wildtype control. The data are 
adapted from Cao et al. (2012)(111). 
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Figure 2-1. Expression Patterns of the 2.3-kb Col1a1 Dkk1-Transgene (Tg) During 
Tooth Development. Immunohistochemical staining showing Dkk1 expression patterns in 
both WT and Tg mice during different stages of mouse tooth development. (A) At E16.5 
Dkk1 is highly expressed in the Tg mouse alveolar bone (AB) with no signal in the molars 
(right panel) compared to the age-matched control (left panel).  (B) In the Tg newborn 
first molars, Dkk1 is highly expressed in the pulp and odontoblast cells (right panel) 
compared to the age matched control (left panels). (C) In 1-week-old Dkk1-Tg mouse 
molars, the Dkk1 signal was maintained high in both pulp and odontoblast cells. (D) In the 
newborn alveolar bone the Dkk1 signal was detected in both WT (left panel) and Dkk1 Tg 
(right panel) osteoblast cells.  
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Figure 2-2. Dkk1-Tg mice display a severe mandibular molar defect. (A) 
Representative radiograph (upper panels) and µCT (lower panels) images reveal a severe 
molar phenotype in a 1-month-old Dkk1-Tg mandible, including an expanded pulp 
chamber and root canal region in the 1st molar, a small malformed 2nd molar, and lacking a 
3rd molar; (B) Quantitative data based on radiographs (see Sfig. 2C for the measurement 
method) shows a significant reduction of dentin root in the Dkk1-Tg 1st molar (data are 
mean±SEM from n=4 samples, **p<0.01; ***p <0.001 by Student's t-test). The 1st molar 
dentin thickness was calculated based on SEM images obtained from 4 WT and 4 Tg 1-
mo-old samples. (C) Images of an acid-etched resin-embedded 1-month 1st molar with a 
striking difference between the well-organized WT dentin tubules (left panel) and the 
irregular dentin structure in Dkk1-Tg mouse (right panel). Quantitative data showed a 
significant reduction of dentin tubule numbers in Dkk1-Tg mouse (middle panel, data are 
mean±SEM from n=4 samples, **p<0.01).  (D) 1-month 1st molar fluorochrome-labeled 
sections of the lower first molar from WT (left panel) and Dkk1-Tg mice (right panel) 
unveiled a reduction of the dentin mineralization rate in the Tg mice. Scale bar=200 µm. 
Quantitative analysis shows a significant difference in the dentin appositional rate between 
the WT and Tg first molar (data are mean±SEM from n=4 samples, ***p<0.001 by 
Student's t-test).  
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Figure 2-3. Dentin Erosion in the Dkk1-Tg Lower First Molar. (A) Backscattered SEM 
images displaying a reduced dentin thickness and areas of dentin erosion in Dkk1-Tg 1-
month-old molars (right panel). (B) Immunostained images show a strong Dkk1 
expression in pulp/odontoblast cells plus a weak expression of Dkk1 in the Dkk1-Tg PDL 
and acellular cementoblasts in the 1-month-old molars. The number of acellular 
cementoblasts appears to be reduced (right panel) compared to the age-matched WT 
control (left panel), exposing the dentin to osteoclast erosion. (C) TRAP (Tartrate resistant 
acid phosphatase) stained images showing more TRAP+ cells in the Dkk1-Tg mouse AB 
with a few in the eroded dentin and PDL region (right panel). A majority of the PDL 
region was occupied by fibrous-like cells with few acellular cementoblast cells in the 
Dkk1-Tg mouse. Dkk1-Tg mice appear to be lacking a polarized odontoblast layer. (D) 
Quantitative TRAP staining data showing a significant increase in osteoclast number in the 
Dkk1-Tg mouse (data are mean ± SEM from n=6 replicates, ***p<0.001 by Student's t-
test). (E) The µ-CT images confirmed the expanded PDL region and eroded root surface in 
the Dkk1-Tg mouse (right panel, arrows). AC: Acellular Cementoblasts; D: Dentin; Od: 
Odontoblast; PDL: Periodontal Ligament). 
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Figure 2-4. Dkk1-Tg mice have an increased expression of Osx in immature molar 
odonotblasts. (A-B) Immunohistochemical data showed that Osx was mainly expressed in 
odontoblast (Od) layer in the wild type (WT, left panels), whereas Osx was widely 
expressed in immature odontoblast cells in Dkk1-Tg pulp (right panels). (C) 
Immunohistochemical data revealed a marked reduction of nestin in Dkk1-Tg dentin (right 
panel) compared to the WT (left panel). Pd, predentin.    
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Figure 2-5. Dkk1 expression pattern during post-natal tooth development. At a 
higher concentration (1:25), Dkk1 is expressed in ameloblast (Am), odontoblast (Od), 
and pulp cells of lower molar and incisors. 
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Figure 2-6. Radiograph image displays absence of 3rd mandibular molars in Dkk1-
Tg mice. (A) Representative radiographs of 2-week-old Tg lower jaws, revealing lack of 
3rd molar in the Dkk1-Tg mandible (6/6). (B) Representative radiographs of 1-month-
old lower jaws displaying no signs of 3rd molar (6/6). (C) A representative radiograph of 
1-month-old lower jaw which was used for measurement of tooth length (left panel). A 
schematic 1st molar based on this x-ray shows how the full tooth length and the tooth 
root length were calculated: full tooth length—the distance between the top of the crown 
and the bottom of the root; and root length—the distance between the top of the pulp 
chamber and the bottom of the root. 
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Figure 2-7. Relatively mild maxillary molar phenotype present in Dkk1-Tg mice. 
(A) With a polyclonal antibody against Dkk1 (1:200), a high Dkk1 signal is detected in 
Tg pulp (P) and odontoblast (Od) cells obtained from both the maxilla and the mandible. 
(B) Representative photographs of the upper extracted molars from WT (upper panel) 
and Dkk1-Tg mice (lower panel) reveal a minor defect in the Dkk1-Tg maxillary molars, 
including a reduction in the root diameter of the 2nd molar and the absence of one tooth 
root in the 3rd molar. 
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Figure 2-8. Unpolarized odontoblasts (Od) in the Dkk1-Tg mandibular molar. 1-
month-old 1st molar showing unpolarized odonotoblasts, suggesting that an over-
expression of Dkk1 inhibits odontoblast cell maturation. 
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Figure 2-9. 2.3-kb Col1a1 promoter activity in both pulp and odontoblast cells. To 
document activity of the 2.3-kb Col1a1 promoter, we crossed the 2.3-kb Col1a1-Cre 
mouse (generously provided by Dr. Barbara Kream from the University of Connecticut) 
to a Rosa 26 lacZ report mouse line (purchased from Jackson Lab, West Grove, PA, 
USA). The offspring (3 wks old) was sacrificed, and a lower jaw was isolated for β-Gal 
staining overnight, followed by H&E count staining. The blue-stained signal, reflecting 
the 2.3-kb Col1a1 promoter activity, is observed in both pulp and odontoblast cells in the 
crown (left panel) and the tooth root (right panel). 
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Figure 3-1. Schematic of Dkk1-Tg mice promoter construct and relative expression 
levels of the Dkk1-transgene. A) Schematic of the DNA construct used to generate 2.3-
kb Col1a1 Dkk1-Tg mice. B) Dkk1 mRNA expression in parietal bones of 4-day old 
calvaria evaluated using RT qPCR (real time). Wild-type control mice expression levels 
were set to 1, and relative expression levels of Dkk1-Tg mice are shown. *P < 0.01 
(showing a significant difference); WT, n = 3; Dkk1-Tg, n = 3.  
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Figure 3-2. Calvarial osteolytic lesions develop in 2.3-kb Col1a1 Dkk1-Tg mice. A) 
Full body photographs displaying overall decrease in body size in 2-week-old Dkk1-Tg 
mice compared to WT control animals. B) Graphical display comparing average body 
weight of Tg and WT animals: WT: 6.4g; Dkk1-Tg: 5.8g. (n = 8 per group; *p < .05) C) 
Relative to non-transgenic wildtype (WT) littermates, radiographs of 2-week, 3-week 
and 8-week 2.3-kb Col1a1 Dkk1-transgenic mice exhibit significant areas of reduced 
radiodensity within the calvarial bones (specifically in the parietal bone). 
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Figure 3-3. Microcomputed tomography (µ-CT) displays mineralization deficiency 
in calvarial bones. A) µ-CT imaging displays Dkk1-Tg calvarial bone mineralization 
defects (most strikingly in the parietal bones) at P0, 4-weeks, and 12-weeks. B) Images 
of individually contoured (selected) out parietal bones of 4-week-old WT and Dkk1-Tg 
parietal bones using µ-CT software presents with greater than a 60% decrease in Bone 
Volume/Total Volume (bone volume fraction), as well as a reduction in Apparent 
Density and Material Density. 
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Figure 3-4. Decreased dendritic processes, misshapen osteocytes, and decreased 
mineralization in Dkk1-Tg parietal bone. A) FITC (Fluorescein isothiocyanate) 
labeled parietal bone regions showing osteocytes with decreased dendritic processes in 
4-week-old 2.3-kb Col1a1 Dkk1-Tg mice. B) Backscatter-SEM imaging revealing a non-
continuous 4-week-old parietal bone with non-abutting parietal bones in the sagittal 
suture with the bone regions pointed to with white arrows, compared to WT littermate 
controls. C) Enlarged 4-week-old WT parietal bone region and Dkk1-Tg parietal bone 
displaying a mineralization defect and malformed osteocytes within the bone matrix. D) 
4-week-old Acid-Etched SEM images of WT parietal bone and Dkk1-Tg parietal bone 
further confirming the presence of defective osteocyte canaliculi and regions of poor 
mineralization as well as the accumulation of osteocytes in small regions. 
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Figure 3-5. Normal suture fusion of Dkk1-Tg posterior frontal bones. Posterior 
frontal bone suture fusion (left images – enlarged on bottom) occurs in normal wildtype 
calvarial development. Dkk1-Tg (right images – enlarged on bottom) posterior frontal 
bones fuse normally with no inadequacy in suture fusion. 
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Figure 3-6. Increase in ecto-cranial bone formation and a decrease in endo-cranial 
bone formation in Dkk1-Tg parietal bone. A) Double calcein labeling shows 
differential bone formation when comparing the ecto-cranial and endo-cranial surfaces. 
B) Graphical display of the endo-cranial surface (left two bars) showing bone resorption 
with relatively no bone growth. Endo-cranial bone formation rate was decreased 
approximately 4-fold. Graphical display of the ecto-cranial surface (right bar graphs) 
showing an increase in bone production. Ecto-cranial bone formation rate was increased 
approximately 0.5-fold. *P < 0.05 (showing significant difference); WT, n = 3; Dkk1-Tg, 
n = 3.  
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Figure 3-7. Increase in Dkk1-Tg osteoclast maturation and activity. A) TRAP 
stained WT control and Dkk1-Tg parietal bones display an increase in TRAP+ stained 
osteoclasts on the endo-cranial surface of Dkk1-Tg parietal bones. B) In Dkk1-Tg 
parietal bones, both Trap and Cathepsin-K mRNA expression increased 9.5 fold and 
Mmp-9 expression increased 5.5 fold. C) Opg gene expression was unchanged compared 
to the WT control bones, but Rankl expression was increased 2.5 fold and M-csf 
expression was increased 1.8-fold. Relative expression of mRNA relative to a Gapdh 
internal control. Dkk1-Tg mRNA gene expressions compared to a normalized WT 
control (WT = 1) mRNA gene expression for all genes tested. Dkk1-Tg levels are shown. 
*P < 0.01 (showing significant difference); WT, n = 3; Dkk1-Tg, n = 3.  
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Figure 3-8. Wnt/β-catenin signaling in Dkk1-Tg mice: Increased in osteoclasts and 
decreased in osteoblasts and osteocytes. Dkk1-Tg;TOPGAL 2-week parietal bones. 
WT parietal bone shows distinct β-galactosidase staining in osteoblasts, osteoclasts and 
osteocytes. Dkk1-Tg parietal bone shows β-galactosidase staining in the osteoclasts but 
not within the osteocytes or osteoblasts. 
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Figure 3-9. Increase in trabeculation in the under-mineralized bone as well as an 
increase in Osx: an osteoblast marker. A) 2 week-old WT (left) and Dkk1-Tg (right) 
parietal bone H&E staining showing the disrupted bone matrix with interspersed fibrous-
like tissue between the woven bone trabeculae, B) 2-week-old WT (left) & Dkk1-Tg 
(right) immunohistochemical (IHC) staining showing increased Osx expression in the 
immature osteoblasts that accumulate within the immature bone adjacent to the partially 
mineralized areas of parietal bone. 
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Figure 3-10. Increase in Osx gene expression independent of Runx2. Real-time PCR 
performed on 2-week parietal bone showing no change in Runx2 gene expression, but an 
unexpected approximately 4.5-fold increase in Osx gene expression. Relative expression 
of mRNA relative to a Gapdh internal control. Dkk1-Tg mRNA gene expressions 
compared to a normalized WT control (WT = 1) mRNA gene expression for all genes 
tested. Dkk1-Tg levels are shown. *P < 0.01 (showing significant difference); WT, n = 3; 
Dkk1-Tg, n = 3.  
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Figure 3-11. An increase in immature osteoblast markers Bsp and Opn in Dkk1-Tg 
parietal bone. A) 2-week-old WT (left) & Dkk1-Tg (right) immunohistochemical (IHC) 
staining showing increased Bsp expression in the immature mineralized matrix. B) 
Increased Opn expression in the mineralized matrix in Dkk1-Tg (right) compared to WT 
(left). 
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Figure 3-12. An increase in expression of immature osteoblast markers: Bsp, Opn 
and Alp, along with a decrease in expression of Ocn, a mature osteoblast marker 
within the Dkk1-Tg parietal bone. A) Real-time PCR performed on 2-week parietal 
bone showing approximately a 3.0-fold increase in Bsp expression, a 2.8-fold increase in 
Opn expression, a 3.2-fold increase in Alp expression and a 5-fold decrease in Ocn 
expression. Relative expression of mRNA relative to a Gapdh internal control. Dkk1-Tg 
mRNA gene expressions compared to a normalized WT control (WT = 1) mRNA gene 
expression for all genes tested. Dkk1-Tg levels are shown. *P < 0.01 (showing a 
significant difference); WT, n = 3; Dkk1-Tg, n = 3. 
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Figure 3-13. Increase in parietal bone Sost and Dmp1 in Dkk1-Tg calvaria. A) 2-
week-old WT (left) & Dkk1-Tg (right) immunohistochemical (IHC) staining showing 
increased Sost expression in the immature osteocytes. B) Increased Dmp1 expression in 
the mineralized matrix in Dkk1-Tg (right) compared to WT (left), with no expression in 
the fibrous-like mesenchymal tissue which lacks any mineralization. 
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Figure 3-14. Increase in Sost and Dmp1 gene expressions in Dkk1-Tg primary 
parietal bone assay. Real-time PCR performed on 2-week parietal bone showing a 3.0-
fold increase in Sost, and a 4.5-fold increase in Dmp1. Relative expression of mRNA 
relative to a Gapdh internal control. Dkk1-Tg mRNA gene expressions compared to a 
normalized WT control (WT = 1) mRNA gene expression for all genes tested. Dkk1-Tg 
levels are shown. *P < 0.01 (showing significant difference); WT, n = 3; Dkk1-Tg, n = 3.  
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Figure 3-15. Working Hypothesis: Dkk1 indirectly induces Osterix expression. 
Dkk1 directly inhibits the Wnt/β-catenin signaling pathway impeding downstream bone 
formation. Our hypothesis supports the theory that Wnt signaling has an inhibitory effect 
on BMP regulation of Osterix expression. Dkk1, being a Wnt inhibitor, is able to 
regulate Osterix expression through its suppression Wnt activity thereby removing the 
block on BMP induced Osterix expression. Osterix then regulates RANKL and M-CSF 
expression to promote osteoclastogenesis and prevents the differentiation of immature 
osteoblasts to mature osteoblasts promoting an osteogenic defect. 
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